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A B S . T R A C T
A number of organochlorine insecticides have been examined for 
both their in vitro and in vivo effects on the biphenyl system for detecting 
potential carcinogens. This test is based on previous findings that biphenyl 
2-hydroxylase can be selectively enhanced by carcinogens. DDT, DDE, DDD 
and aldrin caused a statistically significant in vitro stimulation of 
biphenyl 2-hydroxylation after an initial preincubation period with liver 
microsomes. Dieldrin, however, elicited such a change without any pre- 
incubation. These increases were difficult to interpret since it was shown 
that at least part of the apparent stimulation produced by known carcinogens 
such as safrole, 3-methylcholanthrene and 3^-^enzpyrene, was due to the 
generation of fluorescent metabolites that interferred with the determination 
of 2-hydroxybiphenyl formation in the assay used.
Single intraperitoneal administration of test chemicals to rats 
showed that the carcinogen, 3-me‘thylcholanthrene, caused a selective 
enhancement of biphenyl 2-hydroxylase activity whereas phenobarbitone 
affected both the 2- and k- hydroxylases to a similar extent. However, 
induction patterns observed for compounds such as o<-benzene hexachloride, 
which is carcinogenic, or 5-benzene hexachloride, which is noncarcinogenic 
to rats, showed no differences.
A long-term feeding study was carried out in rats with dietary 
DDT at 250 ppm and 500 ppm. Histological, histochemical and ultrastructural 
alterations in the liver were compared with sequential measurements of 
hepatic drug-metabolizing enzyme activity. Induction of these enzymes was : 
observed within 10 days of feeding, and this was sustained throughout the
experimental period. There was no evidence of liver injury in animals 
of either dose group up to the termination of treatment at 8 months.
"False facts are highly injurious to the progress 
of science, for they often long endure; but false 
views, if supported by some evidence, do little 
harm, as every one takes a salutary pleasure in 
proving their falseness".
Charles Darwin 
The Descent of Man.
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CHAPTER ONE
I N T R O D U C T I O N
I N T  R 0 D U C T 1 0  N
The advent of the use of pesticides has offered enormous 
Benefits' to mankind by controlling many insect-vector borne diseases 
and by greatly increasing food production. The control of a particular 
disease not only has a direct clinical benefit but it also has various 
economic consequences, such as decreases in costs of medical treatment 
and decrease in loss of time at work. In some countries, where the 
possibility of famine may be eliminated by increasing yields of food crops, 
pesticides contribute as much to health as to the economy.
Pesticides may broadly be defined as any substance or mixture 
of substances used for preventing, destroying, repelling, or mitigating 
the effect of, any pest. Fungicides, herbicides, insecticides, acaricides, 
molluscicides, nematocides and rodenticides are classes of pesticides 
employed to control pests ranging from fungi to rodents. Of all pesticides, 
insecticides are the most commonly used although the production and use 
of herbicides are increasing rapidly. The most widely used insecticides 
are the chlorinated hydrocarbons, especially DDT (1,1,l-trichloro-2,2- 
bis(p-chlorophenyl)ethane), and these have been of greatest importance in 
the control of insect-borne diseases of man.
Although the synthesis of DDT was reported over 100 years ago, 
in 187^ by Zeidler, the discovery of its insecticidal properties did not 
occur until 65 years later (Muller, 1939) • By 19^, the hazards of war 
led to its use in the prevention of typhus epidemics, and subsequent 
commercial development led to its extensive marketing for the control of 
household insect pests and many other insects that were doing serious 
damage to food crops. DDT was also found to be invaluable in controlling
the malaria-carrying mosquito, saving millions of lives as a result of its
application.
At the peak of its production between 1962 and 196 ,^ some 250 
tons per annum of DDT and DDD were used for agricultural pest control in 
England and Wales alone (Brooks, 1972). At least five times as much was 
used in the U.S.A. (Matsumura, 1972). However, since I965 the production 
of DDT, and other chlorinated insecticides, such as aldrin and dieldrin, 
has been substantially decreased due largely to previous indiscriminate 
use, their persistence in the environment and their toxic effects on 
wildlife. These factors led to concern about the possible long-term 
effects of these chemicals on human health since insecticide residues have 
been detected in many items of the human diet and also in the human 
cadaver (Duggan, 1968; Abbott et al., 1968, Mes and Campbell, 1976).
Hence, by the end of 1969» DDT was heavily restricted in North America 
and many European countries although the use of the insecticide continues 
to be of great importance to developing countries which are faced with 
particular problems in agricultural and public health. The hazard to 
wildlife and presence of low residues in human fat (Fiserova-Bergerova et
V
al., I967) niay be regarded as of relatively less importance in these 
countries (Brooks, 197^0 especially in view of the present more selective 
application of this pesticide. The possible hazards to human health, and 
to the ecology of other animal species, in more temperate climates, still 
persist, however, as these persistent chlorinated pesticides become 
globally distributed because of their volatility.
General structure and chemistry of organochlorine insecticides
Chlorinated hydrocarbon insecticides may be classified into 
three major groups namely, DDT analogues, benzene hexachloride isomers 
and cyclodiene compounds. These compounds are characterized by the 
presence of carbon, hydrogen and chlorine atoms including a number of 
C-Cl bonds; they also contain cyclic carbon chains (including benzene 
rings). Their non-polarity and lipophilicity makes them extremely 
persistent in the environment and they can remain stored in adipose and 
other tissues of animals and man for long periods of time (Roan et al.,
1971).
The chemical structures and some properties of various chemicals 
in these three classes of chlorinated insecticides are presented in Fig.
1.1 and Table 1.1 respectively.
DDT and related compounds
DDT is generally prepared via the condensation of 1 mol of 
chloral with 2 mols of chlorobenzene in the presence of condensing agents 
such as concentrated sulphuric acid or oleum at a temperature below 20°C. 
The technical grade product contains about 70% of the pure p,p'-DDT with 
o,p'-DDT as a major contaminant. At least ten other minor products are 
present in technical DDT due to side reactions of chloral and chlorobenzene
Agricultural products of DDT are available as wettable powders 
(l - 10^) and emulsifiable (25 - 50%) concentrates for the control of 
phytophagous insects. DDT is commonly used at household in the form of 
aerosol spray; the pesticidal synergist piperonyl butoxide and a pyrethrin 
are normally added for more effective action on insects.
Fig 1.1 Structures of some organochlorine insecticides
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Related compounds of DDT are not as active in their insecticidal 
action as p,p'-DDT; for example, o,p'-DDT is not as insecticidal as p,p'- 
DDT and p,p'-DDE (l,l-dichloro-2,2-bis(p-ehlorophenyl)ethylene) is non- 
toxic to insects. Methoxychlor (l, 1,1-trichloro-2,2-'bis(p-methoxyphenyl)- 
ethane) and DDD (l,1-dichloro-2,2-bis(p-chlorophenyl)ethane) are important 
DDT analogues, valuable for control of various insect pests. They are 
not accumulated to any great extent in animal fat, nor excreted in milk,
and are therefore, preferred to DDT when agriculturally suitable.
DDT, in the presence of strong alkali, is readily dechlorinated 
to DDE even at relatively low temperatures (50°C). Decomposition of DDT 
to DDE also occurs at temperatures above its melting point when catalysed by 
ultraviolet light and ferric chloride.
Benzene hexachloride
Benzene hexachloride (l,2,3,^*5>6-hexachlorocyclohexane) is 
prepared by the chlorination of benzene in the presence of sunlight.
The crude product consists of five distinct isomeric forms, the OC-isomer 
comprising some 70% of the total content. The active constituent of 
benzene hexachloride is, however, the T-isomer which is over 500 times 
as active as the tt-isomer to insects. Preparations that consist of 99%
or over of the pure tf-isomer are called lindane.
Lindane has a higher vapour pressure than either DDT or the 
cyclodiene insecticides and was therefore used in vapour dispensers.
The chemical is very stable to the action of heat, light and oxidation, 
but in alkaline solution, dehydrochlorination readily occurs.
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Cyclodiene compounds
The cyclodiene insecticides are highly chlorinated hydrocarbons 
with endomethylene bridged structures prepared by the.Diels-Alder reaction. 
Aldrin and dieldrin are members of the cyclodiene group. Aldrin is formed 
by the condensation of hexachlorocyclopentadiene with bicycloheptadiene. 
Epoxidation of aldrin with peracetic or perbenzoic acid forms dieldrin, 
which is more polar than aldrin. This conversion also takes place 
in plant and animal tissue and in the soil. Aldrin thus produces the 
same toxic effects as dieldrin in animals. Other cyclodiene insecticides 
include compounds such as aldrin, isodrin, mirex, heptachlor and chlordane.
Aldrin is, in fact, the common name for a technical preparation 
which contains at least 95% of HHDN (l,2,3»^»10>f0“hexachloro-l,4,ha,5>8, 
8a-hexahydro-l, 5 > 8-endo-exo-dimethanonaphthalene). Similarly, dieldrin
is the common name of a technical insecticide consisting of at least 
85% HEOD (l,2,3»^»10,10-hexachloro-6,7-epoxy-l,k,4a,5,6,7»8,8a-octahydro- 
1 5 »8-endo-exo-dimethanonaphthalene).
Metabolism of organochlorine insecticides
Organochlorine insecticides are xenobiotics, i.e. they are 
foreign to the animal body, and many are detoxified enzymically to less 
toxic or harmless products. These lipophilic foreign compounds are 
converted to more polar substances and are readily eliminated from the 
animal body. However, in some cases, conversion of xenobiotics to more 
toxic substances occurs. The metabolism of these chemicals is therefore 
important in determining their fate and their biological action in the 
animal body.
Metabolism of DDT
In mammals, the major metabolite of DDT is DDA, which is more
polar than its parent compound, and is eliminated in faeces and urine (Fig.
1.2). Jensen et al. (1957) found complexed DDA in both bile and faeces of
lA
rats after oral administration of C-labeled DDT. Their data suggested 
that biliary excretion is responsible for almost all of the DDT metabolites 
in faeces, but since bile metabolites consisted of a greater amount of 
free DDA, modifications of these products may have occurred in the intestinal 
tract. Pinto et al.(1965) isolated complexed DDA from faeces and urine of 
rats administered DDT. Three distinct DDA conjugates of p,p'-DDA with 
aspartic acid and serine were found in the faeces in equimolar proportions. 
DDE, in small amounts, was also found as a metabolite in both these studies 
(Jensen et al., 1957; Pinto et al., 1965). .
The presence of DDD as an intermediate of DDT metabolism in 
both animals and plants is well known (Datta et al., 19^; Finley and 
Pillmore, 1963; Morello, 19^5). Peterson and Robison (19&0 suggested 
that DDA may be formed from DDD vxa reactions as follows: DDD— ► DDMU 
DDN3— ►DDNU— ►DDOH— ► DDA (see Fig. 1.2) . Evidence for such a pathway 
came by the administration of each intermediate followed by the 
identification of its major metabolite in the liver. The metabolism of
DDOH was, however, not examined and this was a presumptive step.
Ring fission of DDT has been studied in the rat following a single
oral dose of uniformly labeled "^C-DDT (Abou-Donia and Menzel, 197&).
Of the total radioactivity administered, 1.6$6 was recovered in the expired 
air and although this may not be a major route of DDT excretion, it is
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Fig 1»2 Major pathways of the metabolism of DDT
Abbreviations: rDDMU- l-chloro-2,2-bis(p-chlorophenyl)ethylene 
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equal to the amount excreted in the urine. Over 80% of the C was.excreted 
in the faeces of these treated rats with 10% remaining in body tissues.
. Administration of DDT in the diets of mice and hamsters results 
in the excretion of a substantial amount of DDA and its glucuronide, 
glycine, alanine and serine conjugates in the urine of these animals 
(Wallcave et al., 197 ;^ Gingell, 1976).• Of interest, however, is the 
presence of a relatively large amount of DDE in the urine of mice after 
DDT treatment since this metabolite is absent, or present only in trace 
amounts, in the excreta of hamsters (Gingell, 1976) or rats (Jensen et a J L . , 
1957). In these experiments, urinary DDE in the DDT-treated mouse became 
nearly as prominent as DDA, which was about 8% of administered DDT, after 
4 months of dietary feeding (Wallcave et al., 197^).
DDE has been considered to be a very stable metabolite of DDT 
since no other product, but unchanged DDE was found in liver and kidney 
samples of DDE-treated rats. (Peterson and Robison, 196^)V However, four
phenolic metabolites of p,p'-DDE have recently been identified in rat 
faeces after DDE treatment (Siindstrom, 1977)• The major metabolite,
1, l-dichloro-2-(4-chloro-3-hydroxyphenyl)-2-(^-chlorophenyl)-ethylene, as 
identified by spectral chromatographic comparison with synthetic materials, 
was, however, less than 5% of the dose of DDE (20 mg per animal). Datta 
(1970) indicated that slow conversion of DDE to DDA also occurs in the 
rat but without DDMS as an intermediate, as with DDD (Peterson and Robinson, 
196^).
In pigeons, as in the rat, metabolism of DDT to DDE and DDD by
separate pathways occurs (Bailey et al., 1969). ¥hen DDD is fed to
pigeons, it gives rise mainly to DDMU with very small amounts of DDE.
The metabolic pathway of DDT for pigeons is common to that of the rat as
far as DDMU but further metabolism of this intermediate does not appear
to occur in birds (Bailey et al., 1969; Bunyan et al., 1970, :1972).
In man, oral ingestion of DDT, DDD or DDA produces predominantly 
the readily excreted DDA (Roan et al., 1971)• Tbe conversion of DDT to 
DDD is of critical importance in regard • to its further degradation to
DDA (Morgan et al., 1971).
The conversion of DDT to DDE constitutes the main pathway for 
the metabolism of DDT in insects, although other products have been discovered. 
The ability to convert DDT to DDE appears to be the major cause for the 
resistance of DDT-resistant houseflies (Stenburg et al., 1950). Kimura 
and Brown (1964) also found that DDT-resistant larvae of the yellow-fever 
mosquito produced more DDE from DDT than did susceptible individuals.
Metabolism of aldrin/dieldrin
Conversion of aldrin to its epoxide analogue dieldrin has been 
demonstrated in mammals, soil microorganisms, plants and insects (Wong and 
Terriere, 1965; Ferguson and Korte, 1977; Lichtenstein and Corbett, 1969;
n ilf.
Brooks, i960). C-Aldrin, when given to rats, results in the presence
of aldrin, dieldrin and considerable amounts of a mixture of hydrophilic 
metabolites (up to 75% in the faeces and 95% in the urine) in their 
excreta (Lugwig et al., 1964).
Korte and Arent(1965) isolated six different metabolites from 
urine of rabbits after oral administration of C-dieldrin. The major 
metabolite, identified as one of the two enantiomorphic isomers of 6,7- 
transdihydroxydihydroaldrin, amounts to about 86% of the total products.
This compound, when given intravenously to rats, gives rise to a more
Cl Cl
Aldrin
Cl Cl Cl Cl
micro 
organisms P. americana
photodieldrin dieldrin
Cl Cl Cl .Cl
dieldrinOH9-hydroxy- 
dieldrin
faeces urine
Cl Cl
dihydroxy- 
dihydroaldrin
Cl Cl
6.7-trans-
dihydroxy- 
dihydroaldrin
Cl Cl
COOH
COOHaldrin-dlacid
Fig. 1.3 Major pathways for the metabolism of aldrin and dieldrin
hydrophilic compound which is likely to be its corresponding diacid.
However, the major urinary metabolite of dieldrin in the rat was identified 
as 2-ketodieldrin by Richardspn et al.(l968) and this was subsequently 
confirmed by Matthews and Matsumura (I969).
9-Hydroxydieldrin, the major faecal metabolite of dieldrin in the 
rat, was identified by Baldwin et al.(1970) employing infra-red spectra 
and paramagnetic resonance spectra. The production of 9-hydroxydieldrin 
as a major metabolite is also found in the sheep (Feil et al., 1970).
The faecal route of excretion of dieldrin from the animal body is of greater 
importance than the urinary route and the amount of radioactivity present 
in faeces is at least ten fold more than that found in the urine of mice 
treated with -dieldrin (Matthews et al., 1971).
A comparison of the metabolism of dieldrin in the mouse and rat 
has been undertaken by Baldwin et al.(l972) and also by Hutson (197&)» 
who also compared the metabolism of the insecticide in two strains of 
mice. With the exception of 2-ketodieldrin, which is present only in 
trace amounts in the CF-1 mouse but relatively abundant in the CFE rat, 
urinary metabolites produced by the rat are also present in the urine of 
the mouse although more rapid metabolism occurs in the rat (Baldwin et al,. 
I972). Another difference between rats and mice is the excretion of polar 
complex of metabolites by mice but not by fats. Metabolism of dieldrin 
is very similar in the CF-1 and LACG mouse strains and the only significant 
difference found was that the excretion of dieldrin and its metabolites 
are lower in the LAGG strain (Hutson, 1976).
There have been relatively few studies in which the metabolism of 
dieldrin to other products in insects are reported. However, the metabolism
of C-dieldrin by dieldrin-resistant strains of mosquito, Gules piniens 
ouiuque fasciatus. into a more polar compound with similar chromatographic 
properties as 6,7-dihydroxydihydroaldrin was shown by Oonnitheus and 
Miskus (196^). Nelson and Matsumura (1973) found 9-hydroxydieldrin in 
the tissues of houseflies after treatment with dieldrin. The major 
metabolite in Perrplaneta americana is apparently cis-aldrinol, whilst in 
Blatte11a gezmanica, it is trans-aldrinol (Nelson and Matsumura, 1973)*
Only a few microorganisms are able to degrade dieldrin (Matsumura 
and Boush, 1967) and the major microbial attack appears to be on the 
nonchlorinated rings. The major product of dieldrin metabolism in micro­
organisms is mainly the ketone derivative, as a result of isomerisation 
of the epoxy ring (Matsumura, 1975)* Matsumura et al. (1970) showed that 
certain microorganisms are capable of forming photodieldrin from dieldrin-- “ 
by isomerisation.
At least two neutral, polar metabolites are present in the 
urine of men occupationally exposed to dieldrin (Cueto and Hayes, 1962).
One of these metabolites has been demonstrated by gas chromatography as 
6,7-transdihydroxydihydroaldrin.
Insecticides are subjedt to attack by a variety of enzymes once 
they have gained access into the animal body. Of particular impbrtance 
in the metabolism of insecticides are reactions catalysed by the 'microsomal 
enzymes' in various tissues, especially the liver. These enzymes are so 
called for they are localised in the microsomal fraction, consisting of 
fragments of endoplasmic reticulum, of cell homogenates. They are also 
responsible for the biotransformation of drugs and other foreign chemicals 
in the animal body. 'Microsomes' are composed predominantly of lipoprotein
and contain-.. 12% of the total cellular protein and approximately 50% of 
the ribonucleic acid. Both the rough and smooth endoplasmic reticulum 
are part of the system but they are morphologically and biochemically 
distinct. Various workers have found that in the rat, hepatic microsomal 
enzyme activities are higher in the smooth endoplasmic reticulum than 
in the rough endoplasmic reticulum (Holtzman et al.,1968; Fouts, 1961). 
However, in the liver of mouse, higher activities of mixed-function oxidases 
in the rough endoplasmic reticulum are obtained than are found in rat, 
guinea pig or monkey liver (Gram et al., 1971).
The microsomal drug-metaboUsing enzyme system
The localisation of an enzyme system in the liver endoplasmic 
reticulum, which is capable of metabolising a variety of drugs'was first 
reviewed by Brodie et al.(1958). The reactions catalysed by this system 
which requires both 0^ and reduced NADP, may include aromatic, aliphatic 
and alieyelic hydroxylations, 0- and N-dealkylations and epoxidation (Parke, 
1968). This multicomponent electron transport system is also involved 
in the metabolism of a variety of endogenous substrates such as steroids, 
fatty acids and bile acids (Kuntzman et ad., 19&5)» and because of a wide 
substrate specificity, it is also responsible for the oxidation, reduction 
and eohjugatioh of drugs, pesticides, carcinogens and numerous other 
industrial chemicals (Conney, 19&7; Parke, 1971). Similar enzymic 
activities are also present in extrahepatic tissues such as the lung 
(Gram, 1973> Hook and Bend, 197&), intestine (Chhabra and Fouts, 197^{
Stoths et al.. 1976), kidneys (Orrenius et al., 1973)> white blood cells 
(Gurtoo et al., 1978) and probably most other tissues containing endoplasmic
reticulum.
Three essential components are required for microsomal mixed-
function oxidase activity. These have been solubilised and separated and 
consist of cytochrome P-^50> an NADPH-linked reductase, containing both 
FAD and FMN, and a stable lipid fraction which was shown to be phosphatidyl­
choline (Lu et ad., 1969; Lu and Coon, 1968). The overall reaction 
mechanism involves the incorporation of one atom of molecular oxygen into 
the substrate while the other is reduced to water. The electrons are 
derived via the flavoprotein reductase, and the reaction may be summarised 
as follows: .
combines with foreign compounds, as well as endogeneous substrates, to 
produce difference spectra of two general types, type I and type II. The 
type I spectrum has a peak at 385 urn and a trough at ^20 nm, while type II
Imai and Sato, I966; Schenkman et al., 1967). In addition, a modified type 
II or reverse type I (M5 nm to ^20 nm peak, 390 nn trough) spectral change 
has been demonstrated<
NADPH + H+ + EH2 + 02 NADP* + RHOH + H20
Cytochrome P-^50 is ubiquitous in distribution, having been
demonstrated in fish (Chambers and Yarborough, 1976), birds (Yawetz et al., 
1968), insects (Wilkinson and Brattsten, 1972), yeast (Wiseman et .&1., 1975) 
and bacteria (Sato et al., 1973)* In its oxidised form, the haemoprotein
has a peak at about ^30 nm and a trough at about 395 nm (Bemmer et al., 1966
The affinity of binding of substrates to cytochrome P-450 can be
estimated by measurement of the spectral constant (K_). The K value,
• S  s
by definition, is the concentration of substrate required for half maximal
spectrum development. Some workers found a good correlation between K 
value for binding and the K^ value for metabolism of type I compounds, 
such as hexobarbitone and aminopyrine (Schenkman et al., 19&7 ; Remmer et 
al., I969). However, in general, these two values are not directly 
correlated (Mannering, 1971a).
Type I compounds do not interact directly with the haem of . 
cytochrome P-450 but reaction with a hydrocarbon residue of the apoprotein 
occurs (Yoshida and Kumaoka, 1975)* Therefore, the extraction of 
phospholipids destroys the type I interaction (Leibman and Estabrook,
1971» Chaplin and Mannering, 1970)* The reverse type I spectral change 
results from the displacement of an endogenous type I substrate from the 
oxidised enzyme (Turner et al., 1977) hy the presence of a compound with 
a hydroxyl group, e.g. an alcohol (Yoshida and Kumaoka, 1975)*
Compounds, which contain a basic amino group, induce the type 
II spectral change by interacting directly with the haem iron of the 
cytochrome (Yoshida and Kumaoka, 1975)• Type II compounds also include 
compounds with oxygen or sulphur atoms containing a pair of non-bonded 
electrons.
Cytochrome P-450, in its reduced form, similarly interacts with 
ethyl isocyanide and characteristically has Soret peaks at 430 nm and 455 nm 
(imai and Sato, 1966). The relative sizes of the two peaks are pH dependent, 
but the sum of the heights are about the same regardless of pH. Changes 
in the pH equilibrium point at which the peaks are of equal magnitude 
have been used in studies of the qualitative differences of cytochrome 
P-450 in microsomes from untreated and 3-inethylcholanthrene-treated
rats (Sladek and Mannering, 1966).
Compounds, such as carbon tetrachloride and chloroform, form 
typical type I spectra with mammalian liver microsomal preparations 
(Reiner and Uehleke, 1971). However, under anaerobic conditions, this 
gives rise to a difference absorption at about 455 nm (Wolf et al., 1977). 
The site of interaction of these compounds with reduced cytochrome P-450 
is dissimilar to the type I binding site since after iso-octane extraction, 
which destroys the type I interaction, the magnitude of spectral binding 
under anaerobic or reduced conditions was increased (Cox et al ., 1976). 
Similar complexes with ferrous cytochrome P-450 have been observed with 
halo thane (Mansuy et al., 1974), methylenedioxyphenyl compounds (Gray, 1975 
Kulkarni and Hodgson, 1976), organic, sulphides(Nastainczyk et al. , 1975)» 
amines (Peterson et al., 1971)> phosphines (Mansuy et al., 1974a) and thiol 
compounds (Nastainczyk et al., 1976).
It is suggested that this complex is due to the formation of a 
highly stable ligand complex of a carbene intermediate with reduced 
cytochrome P-450 (Ullrich, 1977). This hypothesis is strengthened by the 
finding that carbon monoxide, which is a hydrolysis product of dihalo- 
carbenes, is released as a product of the interaction (Wolf et al., 1977)*
Multiplicity of cytochrome P-450
Evidence for the presence of a P-450 ha,emoprotein which differed 
from that found in untreated animals was presented by Sladek and Mannering 
(1966) when 3-^e‘thylcholanthrene was administered to normal rats. This 
new haemoprotein, in its reduced form combined with CO and had a maximum
absorption at 448 nm instead of 450 nm (Alvares et al., 1967). • Its 
binding to ethyl isocyanide also differed in that the peak size at 455 nm 
was specifically increased whilst the 430 nm peak remained relatively 
unaltered; also, on the basis of the pH dependency of the ethyl isocyanide 
interaction, it was concluded that a new haemoprotein (cytochrome P-448) 
was formed (Mannering et al., 1969). Further studies confirmed the 
existence of the new cytochrome by virtue of its spectral binding 
characteristics with various types of substrates (Hildebrandt et al.,
I968; Remmer et al., I969; Mannering, 1971) and its preferential specificity 
towards the metabolism of different substrates (Conney et al., 19&9;
Kuntzman et al., 1969). When animals are treated with phenobarbitone, 
cytochrome P-450 concentrations is greatly increased but remains 
qualitatively similar to that found in untreated animals.
Cytochrome P-450 from rats pretreated with phenobarbitone and 
cytochrome. P-448 from rats pretreated, with 3-methylcholanthrene have been 
solubilised from liver microsomes treated with sodium cholate and fractionated 
by .ammonium sulphate, calcium phosphate gel and column chromatography on 
DEAE-cellulose with a further purification on a CM-cellulose column 
(Lu et al., 1976). The two haemoproteins were shown to have different 
molecular weight and different spectral, immunological and catalytic 
properties. This is consistent with the view that the cytochrome P-450 
in liver microsomes prepared from animals induced with drugs is different 
from that induced by polycyclic hydrocarbons.
The lack of substrate specificity of the microsomal mixed-function
oxidase system has led to the suspicion that more than a single species of 
cytpchrome P-450 may exist in the system. One of the advantages of the
presence of several enzymes with a certain degree of specificity is that 
low levels of toxic environmental compounds may efficiently he removed 
from the body. Also, the synthesis of an enzyme effective in the metabolism 
of a particular drug is biologically more economical than to continuously 
synthesize large amounts of a less efficient enzyme (Ullrich, 1977).
Recently, several workers have identified more than one form 
of cytochrome P-450 in liver microsomal preparations of untreated animals 
(Comai and Gaylor, 1973; Haugen et al., 1975; Philpot and Aring, 1976).
Gibson and Schenkman (1978) obtained two forms of cytochrome P-450 (i and 
II) from liver microsomes of untreated rats by lauric acid affinity 
chromatography, with further purification by gel filtration, giving an 
overall 50% yield of the haemoprotein. Marked differences in substrate 
specificities of the two fractions were observed; for example, high activity 
of P-450 II towards the metabolism of ethylmorphine was obtained, but P-450 
I could only poorly metabolise this compound. Their GO difference spectral 
maxima also differed in that P-450 I had its peak between 449.5 and 451 ran 
whilst P-450 II absorbed maximally between 448.5 to 450 nm. The two 
haemoproteins also responded differently towards destruction by linoleie 
acid hydroperoxide.
Multiple forms of cytochrome P-450 have similarly been demonstrated 
in microsomal preparations from either phehobarbiion© or 3-methylcholanthrene- 
treated animals (Guengerich, 1977; Gustafsson and Ingel-Sundberg, 1976;
Thomas etal.,1976, 1976a; Ryan et al., 1975; Coon et 'al., 1975; Lu et 
al.. 1976). Four distinct cytochrome P-450 fractions (A jj, A 2, and C2) 
have been isolated from the liver microsomes of phenobarbitone-treated mice 
(Huang et al., 19?6) by solubilisation with sodium cholate and purification
through several stages, including ion-exchange chromatography. All four 
fractions exhibited different absorption maxima in the reduced CO difference 
spectrum ranging from 449 nm to 451 nm. Testosterone was hydroxylated 
in thel6yj-position by C^ and C2, in the l6(X,-position by C^ and 7c‘v.~position 
by Ag. A^ and A2 fractions possessed high activities towards the metabolism 
of benzpyrene whilst A^ preferentially metabolised 7-ethoxycoumarin and 
coumarin, Benzphetamine was particularly well metabolised by C^.
Therefore, the cytochrome P-450 fractions show preference towards the 
metabolism of various substrates although their substrate specificities 
are broad and overlapping (Lu et al ., 1975).
The cytochrome P-450 population in liver microsomes from 
phenobarbitone- or 3~methylchlanthrene-treated rats is obviously different. 
Cytochrome P-450 preparations from different species of animals treated 
with the same inducer, however, are also different proteins although they 
may have similar catalytic specificity towards different substrates and 
have identical CO difference spectra. Thomas at al.(1976a) found that 
antibodies, produced from the purified cytochrome P-448 obtained from liver 
microsomes of 3“Methylcholanthrene-treated rats, cross-reacted poorly 
with cytochrome P-448 purified from liver microsomes of 3-me"thylcholanthrene- 
treated rabbits.
In separating arid purifying different forms of cytochrome P-450 
from liver microsomes, destruction of haemoproteins often occurs leading to 
low recoveries. The number of forms of cytochroirie P-450 in a particular 
preparation has been postulated with the assumption that the different 
enzymes obtained are not altered or that some forms are not. lost or degraded 
during the purification procedures. Improved techniques of separation and
analysis are, therefore, essential for the interpretation of results with 
any great certainty.
The existence of multiple forms of cytochrome P-450 in a 
microsomal preparation may explain the species, strain, age, tissue and 
sex differences in mixed-function oxidation (Lu and West, 1978). It may 
also explain the kinetics and patterns of inhibition with different substrates, 
inducing agents and inhibitors (Huang et al-,, 1976; Ullrich and Kremers,
■. 19?7).
Interactions of organochlorine insecticides with cytochrome P-450
The interaction of drug substrates with cytochrome P-450 has been 
studied spectrophotometrically and is revealed as an increase or decrease 
in absorbance at wavelengths characteristic for the absorption of haemo- 
proteins. The various types of spectral interaction have been described 
earlier in this chapter. Studies of the interaction spectra of chlorinated 
insecticides with liver microsomal cytochrome P-450 are not extensive and 
have been examined with only a small number of animal species and insecticides.
A type I spectrum has been demonstrated for DDT with liver microsomal 
preparation from rats (Schenkman et al., 1967). The insecticide also gave 
the typical type I difference spectrum with liver microsomal samples from 
the mouse, rabbit or sheep (Kulkarni et al., 1975). Similarly, both aldrin 
and dieldrin interacted with mammalian microsomes to produce the type I 
spectral change. The magnitude of the spectral peak for aldrin was smaller 
than for dieldrin using rat liver microsomal preparations, but the converse 
is true for rabbit liver microsomal preparation. Interaction spectra of
equal magnitude were produced by the two compounds with sheep liver 
microsomal samples (Kulkarni et al., 1975). Greene (1972) observed a 
sex difference in the affinity of binding of aldrin and dieldrin to rat 
liver microsomal preparations, and the interaction spectra were higher in 
the male than in the- females for both substrates.
Type I interactions do not necessarily indicate that the compound 
is a substrate for metabolism nor does it mean that in the absence of such 
an interaction, metabolism would not occur (Hodgson and Tate, 1976). Mirex, 
a chemically stable organochlorine insecticide, gives rise to atypical 
type I spectrum with rat liver microsomal preparations (Baker et al., 1972) 
although no in vivo metabolism of the compound occurs (Mehendale et al.,
1972; Gibson et al., 1972). Mirex, however, causes increases in drug- 
metabolising enzyme activities in both rats and mice (Byard et al. , 1975; 
Fulfs et al., 1977). In contrast, many substrates for the microsomal 
mixed-function oxidases of insecticide susceptible houseflies do not 
interact to form type I spectra (Philpot and Hodgson, 1971a; Tate et -al., 
1973) Lut are metabolised in this strain.
Induction of the drug-metabolising enzyme system by organochlorine 
insecticides .
The rate of drug metabolism by the mixed-function oxidase system 
in hepatic microsomes can be altered by a wide variety of environmental 
factors (Vesell et al., 1976; Gillette, 1976; Conney et al. t 1976). 
Environmental chemicals may inhibit cytochrome P-450 by binding reversibly, 
or binding irreversibly with the haemoprotein, e.g. piperonyl butoxide
(Hodgson et al., 1973) or by causing its destruction, e.g. carbon tetra­
chloride (Greene et al., 1969.). Where the binding is reversible, the 
period of inhibition is followed by enzyme induction. Conversely, many 
chemicals, which include a wide diversity of substances such as halogenated 
hydrocarbon insecticides, polycyclic aromatic hydrocarbons and polychlorinated 
biphenyls, are known to stimulate microsomal cytochrome P-450 enzymes 
(Fouts, 1976; Parke, 1975).
These inducing agents, which cause de novo protein synthesis, 
may broadly be divided into two main classes. The first group may be 
exemplified by drugs such as phenobarbitone which enhances the metabolism 
of a large variety of substrates and induces the formation of cytochrome 
P-450(s). The polycyclic hydrocarbons, such as 3-niethylcholanthrene, 
which stimulate the metabolism of only a limited number of compounds and 
induces the formation of cytochrome P-448(s) are representative of the 
second class of inducers. More recently, compounds such as pregnenolone- 
l6o(-carbonitrile and the chlorinated biphenyls have been demonstrated to 
exhibit enhancing effects on the microsomal mixed-function oxidase system 
differing catalytically from the effects produced by the two known classes 
of inducers (Lu et al., 1972; Alvares et al., 1973).
The first report of a stimulatory effect of an organochlorine 
insecticide on hepatic microsomal drug-metabolising enzymes was provided 
by Hart et al. ( 1963) when rats were accidentally exposed to a chlordane 
spray. Since then, numerous studies have been conducted to examine the 
inductive action of this group of insecticides.
Both chronic feeding or repeated intraperitoneal administration 
of DDT to rats caused various hepatic microsomal enzyme parameters to be 
elevated (Hart and Fouts, 1963). Further studies by the same workers 
showed that the metabolism of various drug substrates was increased even 
at a low dietary concentration of 5 ppm (Hart and Fouts, 19&5). More 
recently, a single high dose of DDT (l60 mg/kg) was found to be sufficient 
to cause a significant increase in the cytochrome P-4-50 content of the liver 
within 2k hours of administration to adult male rats (Vainio, .197*0 • A 
similar observation was obtained for aldrin and dieldrin three days after 
a single injection of either compound (Vainio and Parkki, 1976).
Concern over the effects of chronic, low level exposure of 
organochlorine insecticides to wildlife and to the human population have 
resulted in the undertaking of experiments to find the 'no-effect ' dietary 
level of these compounds to laboratory animals. When a feeding period of 
two weeks was employed, the dose level at which no induction of hepatic 
microsomal enzymes occurred for DDT was between 2 to 5 ppm (Gillett et al., 
I963; Gillett, 1968; Gillett and Chan, 1968; Hoffman et. al., 1970; Den 
Tonkelaar and Van Esch, 197*0* Aldrin, dieldrin and chlordane were also 
found to have similar 'no-effect' levels although the extent of their 
ability to induce microsomal enzyme differs from that of DDT at higher 
concentrations.
Age, sex, duration of exposure and the concentration of a 
compound in the diet are amongst the various factors which influences 
the extent of enzyme induction in experimental animals. The percentage 
increase in microsomal aldrin epoxidase activity was found to be markedly 
higher in DDT-induced young rats than in mature adults (Gillett, 19&9)
Similarly, weanlings exhibited, a greater elevation of hepatic microsomal 
enzyme levels than adult rats when treated with dieldrin (Chadwick et al.,
1975). When exposed to an insecticide, the absorption and distribution 
patterns in the young and adult may differ; also, the rate and route of 
metabolism may possibly determine the extent of inducibility. Indeed,' 
the drug-metabolising system differs both quantitatively and qualitatively 
between adults and neonatal or developing animals (Gram et al., 19&9;
Iba et al., 1977)•
A species difference was observed with the effect of DDT oh 
hexobarbitone sleeping times, Hexobarbitone sleeping times axe shortened 
after administration of DDT to rats but not to mice (Hart and Fouts, 1965). 
Similar observations were made by Cram and Fouts (1967) with two. different 
strains of mice, although the metabolism of zoxazolamine was slightly . 
stimulated in this case. This may indicate that the enzymes for the 
metabolism of hexobarbitone and zoxazolamine may not be identical in the 
mouse. However, the stimulation of both the above parameters and other 
drug-metabolising enzymes in mice was later reported (Abernathy et al.,
1970; Chapman and Liebman, 1971). The possibility that induction by DDT 
in mice required a greater dose level and longer treatment time was 
investigated by Chhabra and Fouts (1973)• Various drug-metabolising enzyme 
activities were increased and paralleled the dosage given and the length 
of treatment, but the elevation of the enzyme activities were of short 
duration compared to the longer lasting effects in rats (Hart and Fouts, 
1965) • These workers with mice, did not, however, include the measurement 
of hexobarbitone sleeping times in their experiment. Differences in the 
metabolism of drugs from one strain of mouse to another (Vesell, 1968;
Kato ..et al., 1970) may possibly provide an explanation to these 
contradictory findings.
In other mammalian species, e.g. squirrel monkeys, DDT is known 
to stimulate microsomal enzyme activities (juchau et al., 1966; Cranmer 
et al., 1972). Dieldrin was shown to be an inducer in horses, cattle and 
sheep, but DDT did not affect drug metabolism in cattle (Ford et al..
1976), possibly due to the rapid metabolism of the compound in this species 
(Crosby, 1967).
Different species of birds responded to DDT and dieldrin in 
varying manners. DDT appeared to depress aldrin epoxidase and aminopyrine 
N-demethylase activities in the Japanese Quail (Gillett and Arscott, 19^9; 
Sell et al., 1972) and White Leghorn laying hens (Sell et al., 1971) 
although cytochrome P-^50 content was unaffected or even increased. In 
immature chickens, however, high dosage of DDT caused a stimulation of ' 
aminopyrine N-demethylase activity (Sell and Davison, 1973). Dieldrin, 
at appropriate doses also gave a varying response in birds. For example, 
at a dose level of 20 ppm, cytochrome P-^50 content was increased although 
the aminopyrine N-demethylase activity was only stimulated in the chicken 
and not in the duck.
Sex differences in the response to organochlorine insecticides 
also occur. The increases effected by dietary dieldrin were markedly less 
in the male than in female rats (Greene, 1972; Stevens et al., 1973)> 
however, in Japanese Quail, no sex difference was observed (Gillett and 
Arscott, I969). The latter observation may be because young animals 
were used, for sex-related differences were not observed in immature
animals (Kato, 197*0 •
In man, drug metabolism is also known to be enhanced under the 
influence of DDT and dieldrin. Workers that were extensively exposed to 
the insecticide had a much greater store of DDT and its metabolites in 
their adipose tissues (Laws et al., 1967)> and were found to have a 
decreased plasma half-life of antipyrine (Kolmodin-Hedman et al., I969).
In another study, the serum half-life of phenylbutazone was lowered and 
the urinary excretion of 6^3-hydroxycortisol was much higher in DDT-workers 
when compared to those of the general population.
The potent and prolonged inductive effects of organochlorine insecticides 
have led to their recognition as potential therapeutic agents. DDT has 
been successfully used in newborn infants suffering from hyperbilirubinaemia 
by increasing hepatic glucuronyltransferase activity (Thompson et al., I969); 
and o,p'-DDD was effective in counteracting the overproduction of cortisol 
in Cushing's syndrome (Bledsoe et al., 196 )^.
Carcinogenicity and mutagenicity of organochlorine insecticides
Besides their ubiquity and persistence in the environment, 
organochlorine insecticides have the ability to accumulate in living 
organisms including man (Kraupl and Karpos, 1976). Concentrations of 
2-8 ppm DDT are present in human adipose tissue (Davis et al., 1968;
Wasserman et al., 1967; Duggan and Lipscomb, 1969) with higher levels in 
those occupationally exposed to the compound (Laws et al., 1967).
Organochlorine insecticide residues have been detected in human breast 
milk (Quinby et al. ,1 9 6 5 > Tanabe, 1972), and DDT and dieldrin have been
shown to cross the placenta in the rabbit (Hart et al., 1972; Hathaway et 
al., 1967). Since DDT residues have been detected In the aborted human 
foetus, it is possible that DDT can also cross the human placenta.
Against this background, and the findings that certain organochlorine 
insecticides can produce tumours in experimental animals, particularly 
mice (Tomatis et al., 1972; Innes et al., 1969)1 concern has been expressed 
over the possible human hazard posed by these compounds.
The study of the carcinogenic potential of chemicals generally 
requires experiments to be performed over the whole life-span of the 
animal species employed since tumours develop after a latent period, which 
is longer the lower the dose and the lower the carcinogenic potential of 
the chemical. Therefore, mammalian species with relatively short life­
span, such as rats, mice and hamsters, are routinely used, with dogs and 
nonhuman primates for special cases. Studies on the possible carcinogenicity 
of organochlorine insecticides have resulted in much controversy, mainly 
due to marked differences in response in different species, and even in 
different strains.
Various long-term feeding experiments of DDT to different mouse 
strains have led to a significant increase in tumour incidence in these 
animals. A higher incidence, compared with control, was obtained when 
maximal tolerated doses (^6 mg/kg) of DDT was given to one week, old mice 
by stomach tube for k weeks, followed by dietary intake at 1^0 ppm for a 
period of 20 months (Innes et al., I969). The hepatocarcinogenicity of 
DDT in mice was shown to be dose-related when animals were maintained on 
diets between 2 to 250 ppm DDT for an entire life-span (Tomatis et al.,
1972). It was also demonstrated that DDT-induced hepatomas did not
regress but continued to grow after cessation of a 30 week feeding study 
at 250 ppm (Tomatis et al., 197*+). Other long-term administrations of 
DDT to mice have also indicated a high incidence of liver tumours, especially 
at a dietary level of 250 ppm or over (Thorpe and Walker; Terracini et al., 
1973; Turusov et al., 1973)* However, no tumours were found when 
Balb/c mice of either sex were given 2 or 20 ppm DDT although male CF-1 
mice responded with an increased incidence of liver tumours at similar 
dose levels. The feeding of aldrin or dieldrin, both at 10 ppm in the 
diet, also produced hepatic tumours in mice although these were considered 
to be benign (Davis and Fitzhugh, 1962).
In multigeneration studies, Balb/c mice developed a progressive 
increase in tumour Incidence from the second generation onwards after being 
maintained on a diet containing about 3 ppm DDT (Kemeny and Tarjan, 1966). 
Tumour types were frequently those of carcinoma of the lungs, reticulum 
cell sarcoma, leukaemia and haemangioendothelioma (Tarjan and Kemeny,
I969). A-strain mice also developed lung adenomas, when exposed to 10 
ppm DDT, with significant increases in F^, F^ and F^ treated generation 
as compared to controls (Shabad et al., 1973)*
An increase in tumour incidence, particularly lymphomas, lung 
adenomas &nd liver tumours, occurred in mice when DDT Was administered by . 
repeated subcutaneous injection; but no evidence of carcinogenicity was 
observed when the insecticide was applied topically (Kashyap et al., 1977) 
although slight liver damage and inflammation of the painted skin were 
found in one early study (Bennison and Mostofi, 1950). A single injected 
dose of 15 g/kg body weight of DDT to newborn Swiss mice did not result 
in a higher incidence of lung adenoma than the control animals six months
after treatment (Gargus et al., 19&9)•
The time period required, before the appearance.of tumours may be 
important in these carcinogenicity studies. Therefore, tumours were not 
detected in mice killed at 55 weeks of age, after a 50 week feeding period 
of 100 ppm dietary DDT (Del Pup et al., 1978), whereas hepatomas were 
found when animals on DDT diets were sacrificed between 70 —  80 weeks of 
age (Turusov et al., 1973; Innes et al., 1969).
Rats appear to be less susceptible to the tumorigenic effects
of organochlorine insecticides. Fitzhugh and Nelson (l9*+7) reported the 
occurence of hepatomas in rats receiving DDT at dietary levels above *+00 
ppm for 2 years, but no dose-dependent relationship was mentioned. More
recently, DDT was found to cause the development of hepatic tumours in rats
after two years or more of maintenance at 500 ppm in the diet (Rossi et al.,
1977). Other studies in rats, however, gave no evidence of carcinogenicity. 
Only one hepatoma was found in a rat when treated with 200 ppm dietary 
DDT for about 2 years (Deichmann et al., 1967). Kimborough et al (196*+) 
failed to demonstrate a significant increase in tumour incidence following 
a long-term administration of 3.5 mg DDT per day to rats, and Weisburger 
and Weisburger (1968) were also unable to find any liver tumours after rats 
were given 10 mg of DDT daily for one year. No increase in tumour incidence 
in either rats exposed to 100 ppm dietary dieldrin or dogs orally given 
0.05 mg/kg/day dieldrin for 2 years could be observed (Walker et al.,
I969), although tumours in various organs were found in some rats in an 
earlier experiment (Fitzhugh. et al., 196*+).
No increase in tumour incidence was found in the Syrian Golden 
hamster even after a 2 year maintenance on a diet containing 1000 ppm
DDT (Agthe et al., 1970). On the other hand, relatively low doses of
DDT gave rise to liver cell tumours in the rainbow trout (Halver -et al., 1962)
The conflicting results obtained in long-term feeding studies 
in experimental animals provide no clear basis for assessing the likely 
hazard of organochlorine insecticide exposure to man. The most consistent 
results in terms of carcinogenicity have Come from studies in mice.
However, the mouse has been criticised as an unsuitable model for 
carcinogenicity studies (C-rasso and Cramp ton, 1972) since, among other 
reasons, many strains of mouse have high spontaneous tumour incidences.
Also, with particular respect to the liver, a number of hepatic microsomal 
enzyme inducers, e.g. phenobarbitone, produce hepatomas in mice but not 
in other animal species.
Most chemical carcinogens are also mutagenic (Miller and Miller, 
1971). Organochlorine insecticides have therefore been examined in a 
number of test systems. DDT, aldrin and dieldrin have been reported to 
cause chromosomal damage in mice {Johnson and Jalal, 1973; Markaryan,
1966; Clark, 197*+). In a cultured cell line from kangaroo rat, DDT, DDD 
and DDE were found to result in chromosomal abnormalities mainly in the 
form of exchange figures (Palmer et al., 197*+) • These results would point 
to DDT as a potential mutagen. Results from other workers, however, 
found DDT to be nonmutagenic in dominant lethal tests with mice (Epstein 
and Shafner, 1968; Epstein et al., 1972) although a positive result was 
obtained with rats under Similar conditions (Legator, 1973). DDT was 
proved to be inactive when applied to a Chinese hamster cell-line whilst 
DDE-treated cells had a significant increase in chromosome abberrations, 
with exchange figures and chromatid breaks being especially evident 
(Kelly-Garvert and Legator, 1973)•
The Ames or Salmonella/microsome test, which employs bacteria 
as sensitive indicators of DNA damage, and mammalian liver extract for 
metabolic conversion of carcinogens to their active mutagenic forms (Ames 
et al., 1973; 1975)» has been applied to the study of the potential 
mutagenicity of several organochlorine insecticides. The assay is 
sensitive for the detection of mutation points of both the frameshift 
and base-pair substitution type. Dieldrin and DDE did not cause any 
mutagenic activity (McCann et al., 1975) and similarly, DDT gave a negative 
response in this system (Marshall et al., 197&).
The effects of DDT, DDD and DDE have been tested In mouse embryo 
cells in culture. Although transformations were produced, the very dense 
transformed foci as caused by the typical carcinogen, 7,12-dimethyl- 
benz(a)anthrene, were not seen. Also, no tumours developed when cells 
were inoculated into syngeneic mice (Lagenbach and Gingell, 1975).
Dieldrin gave negative results in the dominant lethal assay In 
CF-1 mice dosed orally with 50 mg/kg of the insecticide (Dean et al,, 1975). 
Chromosome breakages, gene conversion or dominant lethality was apparently 
not evident in this test. A similarly negative response was obtained
with Chinese hamsters dosed with 60 mg dieldrin/kg. In host-mediated 
assays with CF-1 mice given an oral dose of 50 mg/kg or 10 mg/kg dieldrin 
for five consecutive days, these workers again failed to observe any positive 
response, Short-term lymphocyte cultures obtained from workers in a 
manufacturing plant did not show any degree of chromosome damage higher 
than that found in a control group of workers.
In cultured human cells, aldrin and dieldrin but not DDT, were 
found to induce unscheduled DNA synthesis (Ahmed et al., 1977). This 
effect is characteristic of compounds that are capable of producing DNA
damage, and it was concluded that these insecticides may be potentially 
harmful to man despite their relatively low acute toxicity,
A number of epidemiological studies have been reported by 
making use of human populations occupationally exposed to levels of DDT 
hundreds of times higher than the general population (Laws et al., 196?). 
Despite such high levels of exposure, no clinical abnormalities, as 
determined by routine laboratory tests and chest X-ray examinations, were 
evident. The absence of ex.-fetoprotein in the blood of heavily exposed 
individuals has also been cited as evidence for the lack of carcinogenicity 
of DDT in man (Slomka, 1973) • Similarly, studies of workers exposed to 
aldrin and dieldrin have produced negative results (jager, 1970). The 
significance of the positive results of carcinogenicity in animals in 
terms of risk of human hazard therefore remains unclear.
Aims of project
DDT and other organo chlorine insecticides have been found to 
respond negatively to the Ames test although they are known to raise the 
incidence of tumours in some animal species, particularly when the mouse ; 
is employed as an experimental model. Since these compounds apparently 
do not behave like typical carcinogens,, the development of new test systems 
is both important and necessary to evaluate their carcinogenic potential.
The biphenyl test has been inferred as being a simple and 
inexpensive means of detecting chemical carcinogens (McPherson et al.,
197*+» Parke, 1977). A list of known carcinogens has been reported to
respond positively in this in vitro test system by stimulating the 
hydroxylation of biphenyl at the 2-position, whereas noncarcinogens 
failed to produce a similar effect. In the present project, some 
organochlorine insecticides were applied to the biphenyl system to examine 
the response of this syAtem to. these 'suspect' carcinogens. This is an 
attempt to evaluate the usefulness of this test system to these compounds, 
and possibly to deduce the true carcinogenic potential of such chemicals.
Long-term sequential biochemical and morphological studies 
have been carried out with questionably carcinogenic agents, such as 
dieldrin (Hutterer et al., 19&9; Stevens et al., 1977) and the food colour 
Ponceau MX (Grasso and Gray, 1977)* Various changes in the liver were 
detectable for Ponceau MX during the initial feeding stages, but before 
the appearance of liver cell tumours, and a depression of microsomal 
drug-metabolism activities was observed after rats were kept on continuous 
treatment with dieldrin. A similar study was conducted with DDT to 
further evaluate its biological activity as a 'suspect' carcinogen.
CHAPTER TWO
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ON MAMMALIAN MICROSOMAL HYDROXYLATION OF BIPHENYL
EFFECT OF SOME ORGANOCHLORINE INSECTICIDES ON MAMMALIAN MICROSOMAL
HYDROXYLATION OF BIPHENYL
INTRODUCTION
The generally accepted method of screening a chemical for its
carcinogenic potential is by long-term tests in laboratory animals.
*
These experiments are, however, expensive and time consuming, and it is 
clearly impractical to produce the necessary scale to screen the many 
naturally occurring organic compounds or synthetic chemicals such as 
pesticides, food additives and drugs that may be carcinogenic. Moreover, 
the final assessment of carcinogenicity by such means is often equivocal. 
For example, spontaneous tumour incidence may hinder interpretation of 
results and the differentiation of criteria such as benign and malignant 
tumours, hyperplasia, metaplasia, neoplasia may also be controversial 
(Fishbein, 1976).
A wide variety of short-term test systems with high predictive 
value have recently been developed to identify compounds which may be 
potential carcinogens. Many of these tests are designed for the detection 
of agents that cause damage to DNA in bacterial, mammalian or human 
cultured systems since there appears to be a good correlation between 
mutagenesis and carcinogenesis (Miller and Miller, 1975; Ames et al.,
1975). One of the most successful of these is undoubtedly the Ames test, 
which employs specially constructed strains of Salmonella typhimurium as 
sensitive indicators for DNA damage, and mammalian liver extracts for 
metabolic conversion of carcinogens to their active mutagenic forms 
(McCann et al., 1975; McCann and Ames, 1976).
However, DDT, DDE and dieldrin all gave negative results in 
the Ames test (Marshall et al., 19?6) even though these compounds are 
capable of giving rise to liver tumours in both rats and mice (Rossi 
et al., 1977; Thorpe and Walker, 1973). It appears therefore that the 
Ames test may not be suitable for evaluating the carcinogenic potential 
of compounds such as the organochlorine insecticides.
Carcinogens are also known to exert various effects on the
•ar
endoplasmic reticulum, and these appear to provide promising alternatives 
for carcinogen testing. Pretreatment of animals with polycyclic 
hydrocarbons was found to selectively enhance the hydroxylation of the 
substrate, biphenyl, at the 2-position (Creaven and Parke, I966). Biphenyl 
is predominately metabolised by hepatic microsomes to produce 4- 
hydroxybiphenyl as a major product with 2-hydroxybiphenyl as a minor 
metabolite in many mammalian species (Creaven et al., 1965; Wiebkin et al.,
1976). In vitro preincubation of carcinogens with mammalian hepatic 
microsomes, in the presence of an NADPH-regenerating system, produced 
similar results in that biphenyl 2-hydroxylase was selectively enhanced 
with no significant effect on biphenyl 4-hydroxylase. .Non-carcinogens 
did not enhance either hydroxylase in vitro (Bridges et al., 1973;
McPherson et al., 1974).
It was, therefore, of interest to use DDT and related compounds 
as models to further explore the potential of the biphenyl system as a 
short-term test for carcinogenicity. In this study, the In vivo and 
in vitro effects of organochlorine compounds on biphenyl hydroxylation 
in hepatic microsomes has been investigated. A number of known carcinogens 
were also included for comparative purposes.
MATERIALS AND METHODS
Materials
Biphenyl was twice recrystallised from 96^ ethanol (MP 6g- 
70°). 4-Hydroxybiphenyl and 2-hydroxybiphenyl were twice recrystallised v 
from methanol (MP 166 - 167°) and light petroleum (MP 56 - 57°) 
respectively (Burke, 1972). 3“Methylcholanthrene, glucose 6-phosphate 
dehydrogenase (Type XII from Torula yeast) were obtained from Sigma 
Chemical Co., London. NADP (Boehringer Corporation Ltd., London), 
7-ethoxyresorufin, resorufin standard (Pierce Chemical Co., Rockford,
II., U.S.A.), NADPH (p.L. Biochemicals, Chicago, U.S.A) and phenobarbitone 
sodium (BDH Chemicals Ltd., Poole, Dorset) were used as purchased.
The organo chlorine insecticides, p,p*-DDT (99^0> P iP'-HDD
(99^) and p,p'-DDE (99^) were obtained from Aldrich Chemical Co. Ltd., 
v'set
Gillingham, These insecticides were all shown to give a
single peak by gas-liquid chromatography. Dieldrin, d-benzene hexachloride 
and ^-benzene hexachloride (all 99^%) were supplied through the courtesy 
of Dr. Alan Wright, Shell Research Laboratories, Sittingboume, Kent.
All other chemicals were either general or analytical reagent grade as 
supplied.
Animals
Male Wistar rats (IOO-I5O g), adult male polecat ferrets 
(Mustela putorius) and mature male CF-1 mice (40-60 g) bred by the 
University of Surrey Animal Unit were used. Rats and mice were kept 
as litter-mate cage groups with a maximum of six animals per group.
Ferrets were kept individually in separate cages. All animals were 
maintained under constant environmental conditions as regards to 
temperature, humidity and length of lighting. Water and food were 
provided ad libitum. Animals were killed between 8.30 and 9.30 a.m. 
except those employed for the time-course studies.
Treatment of animals
Compounds studied for their in vivo (rats only) effects were 
administered as a single intraperitoneal dose in corn oil (1.0 ml/ 
animal) with the exception of phenobarbitone which was dissolved in 
0.# (W/v) NaCl solution (l.O ml/animal). Dose levels and compounds 
used were as follows: 3-^ethylcholanthrene (25 mg/kg); safrole (75 mg/&g)» 
phenobarbitone (100 mg/kg); chloroform (0.5 ml/kg); p,p'-DDT (50, 100 or 
200 mg/kg); p,p'-DDE (200 mg/kg); p,p'-DDD (200 mg/kg); aldrin (30 mg/kg); 
dieldrin (5, 15» 30 or ^5 mg/kg), d-benzene hexachloride (50 mg/kg) and 
tt-benzene hexachloride (50 mg/kg). Animals in control groups were 
injected with identical volumes of either corn oil or saline as appropriate.
Preparation of liver fractions
Rats and mice were killed by cervical dislocation and ferrets by 
ether intoxication. The livers were immediately removed, rinsed with 
cold 1.15$ KC1 solution (homogenising medium) to remove excess blood 
and blotted with filter paper. Gall bladders from livers of ferrets were 
removed prior to washing and homogenisation. After weighing, the livers 
were minced with scissors prior to homogenisation in a glass homogeniser 
(size C) using a power-driven, loose fitting Telfon pestle (Potter and 
Elvehjem, 1936). For each sample, three slow up and down strokes were
used. The homogenate was adjusted to a 2 %  solution (i.e. ^ ml = 1 g 
liver) with the homogenising medium and centrifuged in 50 ml polycarbonate 
centrifuge tubes in an M.S.E. 'High-Speed 18’ centrifuge at 10,000 g 
(11,000 r.p.m.) for 20 minutes at ^°C. The resultant supernatant, which 
consisted of microsomes and the soluble fraction, was removed for further 
centrifugation at 105,000 g (40,000 r.p.m.) for 1 h at 4°C in an M.S.E. 
'Superspeed 50' centrifuge with a 8 x 25 angle rotor. The microsomal 
pellet was washed carefully with homogenising medium, after the supernatant 
(soluble fraction) had been discarded, and resuspended in the same 
original volume of KG1 solution employing a size B homogenising vessel.
This fraction thus obtained is the microsomal suspension.
Effect of chemicals on biphenyl hydroxylation
In in vitro studies, organochlorine insecticides were dissolved 
in dimethylformamide (DMF) to a concentration such that the desired final 
concentration in the incubation mixture (see below) could be achieved 
using a maximum addition of 10 jul. With higher volumes, biphenyl k- 
hydroxylase activity was found to be significantly decreased by DMF.
Test compounds were preincubated with hepatic microsomal suspension and an 
NADPH-regenerating system for the desired period of time before the addition 
.of the substrate, biphenyl.
The assay for biphenyl hydroxylation was according to the method
of Creaven et al. (1965) with modifications by McPherson (1975). All
tubes were carried out in duplicate .- Standards included 2-hydroxybiphenyl 
(6 /jig/ml) and 4-hydroxybiphenyl (30yUg/ml). The incubation system 
consisted of the following:
TEST (ml) BLANK (ml)
Buffer:
Tris-HCl, 0.05 M, pH 8.1 
NADPH-regenerating system:
Glucose 6-phosphate (30 mM) -
' t :NADP (4 mM)
Glucose 6-phosphate (<? •. \
dehydrogenase ,
MgCl, (0.05 m)
Microsomal suspension (23%)
Substrate:
Biphenyl, 12 mM in 1.15$ KC1 ' 
containing 2% (v/v) Tween 80
. . 0 . 7 5
0.50
0.25
0.25
0.25
0.75
0.50
0.25
0.25
0.25
Total incubation volume: 2.00 2.00
* addition after incubation.
After an incubation period of 15 minutes at 37°C in a Mickle
shaking water bath (80 cycles/min), the reaction was terminated by the
addition of 0.5 ml 2 N HG1. Substrate and standards were then added to
the appropriate tubes. 7 ml n-heptane (containing 1.5$ isoamyl alcohol)
was then added to all tubes and extraction was allowed for 15 minutes 
on a rotary shaker. Any emulsion formed was dispersed by centrifugation 
at 1,200 r.p.m. for 10 minutes. 2 ml aliquots from the clear layer were 
withdrawn into clean tubes prior to addition of 5 ml 0.1 N NaOH. Further; 
extraction was carried out for 10 minutes on the rotary shaker, after 
which the tubes were centrifuged for 15 minutes at 2,000 r.p.m. After
phase separation, a 2 ml aliquot of the upper alkaline layer was then placed 
in a fluorimetric cuvette followed by the addition of 0.5 ml 0.5N succinic 
acid to adjust the pH to 5.5*
The 2- and 4-hydroxybiphenyls formed were measured using a Perkin- 
Elmer MPF 3 spectrophotofluorimeter at wavelengths 415 nm and 338 nm with 
excitation at 295 nm and 275 nm respectively.
From the reading at 338 nm with 275 nm, 4-hydroxybiphenyl
can be calculated since the 2-isomer does not interfere at this wavelength. 
From the reading obtained at 415 nm with A 295 nm, 2-hydroxybiphenyl can
6XC
be determined after allowing for the contribution of the 4-isomer at this 
wavelength. This contribution was calculated as follows:
Reading of 4-hydroxybiphenyl ' -amount of 4-hydroxybiphenyl in unknown 
standard at 415 nm amount of 4-hydroxybiphenyl in standard
7-Ethoxyresorufin 0-deethylase
Hepatic microsom.es catalyse the 0-deethylation of ethoxyresorufin 
to resorufin. Both compounds are highly fluorescent, and the reaction 
can be followed continuously in the fluorimeter. The method used for 
this assay was essentially that of Burke and Mayer (1974). The reaction 
mixture comprised of 2 ml potassium phosphate buffer (0.1M pH 7.8),
50 jxl microsomal suspension (25$) and 10^ul ethoxyresorufin (50 /aM in 
methanol). The reaction was measured at 37°C in a Perkin-Elmer MPF-3 
spectrophotofluorimeter at an emission wavelength of 586 nm and an 
excitation wavelength of 510 nm with both slit widths at 3*5 nm. r A 
baseline was initially drawn before 10 j&l NADPH (50 mM) was added to 
initiate the reaction, which was recorded on chart paper and allowed to
continue for 2 minutes. The quantity of product formed was calculated 
by reference to an incubation sample containing 10 yul resorufin standard 
(O.l mM). Both substrate and standards were stored in the dark as they 
undergo decomposition in bright light.
Cytochrome P-450
When reduced, cytochrome P-450 combines with carbon monoxide 
exhibiting an absorption maximum at 450 nm, and can therefore be detected 
spectrophotometrically. The method employed was that of Omura. and Sato 
(1964).
Equal amounts of microsomal suspension (containing approximately
2 mg/ml protein, using 0.1 M potassium phosphate buffer pH 7.4 for dilution)
were added to two matched cuvettes. A few granules of sodium dithionite
were added to both cuvettes and carbon monoxide was gently introduced into
the sample cuvette for approximately 30 seconds. A difference spectrum
was then recorded in a Pye Unicam, SP-1800 dual beam spectrophotometer
between 400 nm and 500 nm. The quantity of cytochrome P-450 present
was calculated from the difference in absorbance between 450 nm and 490 nm
-1 1
employing an extinction coefficient of 91 mM" cm" (Omura and Sato,
1964a).
Protein estimation
The method used was based upon the colofcfrimetric determination
of protein by Lowry et al.(1951).
Samples were diluted with 0.5 N NaOH so that the amount of 
protein present was less than 500 yxg/ml. A 0.5 ml aliquot of the diluted
sample was then added, to 0.5 ml of 0.5 N NaOH. 5 ml of a freshly 
prepared copper reagent* was added and mixed. This was allowed to stand 
for 10 minutes before adding 0.5 ml Folin-Ciocalteau phenol reagent 
(diluted 1 in 2 with distilled water). The contents were immediately 
mixed.and the resulting blue colour was read after 30 minutes in a Cecil- 
272 spectrophotometer at 720 nm. Tubes were run in duplicate.
Suitable blank and standards (0 - 250 jug bovine serum albumin)
■f ■ ■
were carried through the same procedure.
* Copper reagent consisted of:
1% CuS0^.5H20    0.5 ml -
2% Potassium-sodium tartrate -----  0.5 ml
2% Na2C0^   50.0 ml
Statistics
Results are expressed as the arithmetric mean + the standard 
error of the mean (S.E.M.). The Student's t-test was used to establish 
significant differences between means.
RESULTS:
In vitro effects of organochlorine insecticides on biphenyl hydroxylation 
by hepatic microsomes
Organochlorine insecticides, at a final concentration of 0.5 mM, 
were preincubated with liver microsomes from rats, mice and ferrets for 
10, 30 and 60 minutes in the presence of an NADPH-regenerating system. 
Generally, biphenyl 2-hydroxylase activity was stimulated after a 
preincubation period of 30 minutes with the insecticides in all three 
mammalian species (Tables 2.1 - 2.3). An exception was that of DDE 
where a decrease in activity of the enzyme was observed, DLL caused 
a greater degree of enhancement than its parent compound, DDT. Aldrin 
and dieldrin exhibited a higher stimulatory effect than DDT and DDD. 
Biphenyl 4-hydroxylase activity in most cases, was significantly inhibited. 
The general pattern of stimulation by the insecticides on biphenyl 2- 
hydroxylase was similar in the three species examined.
Table 2.4 shows the in vitro effects of insecticides on 
biphenyl hydroxylation in the rat when no preincubation was carried out. 
With the exception of dieldrin, which significantly elevated biphenyl 
2-hydroxylation, all the test compounds caused inhibition in both 
hydroxylase activities.
None of the compounds gave rise to fluorescent products that 
interfe/red with the biphenyl assay.
Biphenyl hydroxylation after preincubation of hepatic microsomes with 
different concentrations of DDT and dieldrin
Varying concentrations, of DDT and dieldrin were preincubated
Table 2.1 Effects of preincubation with organochlorine insecticides
on biphenyl hydroxylation by rat hepatic microsomes
Results are mean values for six rats presented as percentages of control 
activity (expressed as nmol/mg microsomal protein) + S.E.M.
The final concentration of each compound in the incubation was 0.5 mM.
* indicates that value is significantly different from control; P<0.05.
Test compound r Preincubation 
time (min)
2-Hydroxylation 4-Hydroxylation
DDT 10 94 + 13 110 + 1 1
30 118 + 2 * 107 + 10 •
6o 113 + 11 91 +14
DDE 10 100 + 3 65 + 3 *
30 73 ± 6 * 5 5 + 5  *
6° 78 + 3 * 1 0 8 + 7
DDD 10 100 + 8 8 7 + 7  *
3° 146 + 16* 81 + 9 * ’
60 110 + 20 72 + 6 *
Aldrin 10 108 + 16 53 + 5 *
30 150 + 21* 6 5 + 7  *
6° 138 + 26* 48 + 3 *
Dieldrin 10 7 7 + 1 2 72 + 2 *
30 144 + 13* 76 + 5 *
60 95 + 6 1 1 1 + 1 0
Table 2.2 Effects of preincubation with organochlorine insecticides
on biphenyl hydroxylation by mouse hepatic microsomes
Results are mean values for six mice presented as percentages of control 
activity (expressed as nmol/mg protein) + S.E.M.
The final concentration of each compound in the incubation was 0.5 niM.
* indicates that value is significantly different from control; P<0,05.
Test compound
f
Preincubation 
time (min)
2-Hydroxylation 4-Hydroxylation
DDT 10 1 2 8 + 7 * 90 + 4
30 1 1 8 + 5 94 + 9
60 75 ± 4 1 0 0 + 6
DDE 10 100 + 1 2 53 + 2 *
30 82 + 9 57 + 1 *
60 100 + 1 2 76 + 9 *
DDD 10 106 + 10 88 + 4 *
30 164 + 24* 8 2 + 7
60 112 + 16 44 + 5 *
Aldrin 10 88 + 1 68 + 1 *
30 126 + 1 * 43 + 5 *
60 135 + 6 * 9 2 + 2
Dieldrin 10 1 0 0 + 5 70 + 3 *
30 118 + 4 56 + 5 *
60 97 + 6 73 ± 5 *
Table 2.3 Effects of preincubation with organochlorine insecticides
on biphenyl hydroxylation by ferret hepatic microsomes
Results are mean values for six ferrets presented as percentages of control 
activity (expressed as nmol/mg microsomal protein) + S.E.M.
The final concentration of each compound in the incubation was 0.5 mM.
* indicates that value is significantly different from control; P < 0 .05.
Test compound
f
Preincubation 
time (min)
2-Hydroxylation 4-Hydroxylation
DDT 10 118 20 73 T 16
30 146 + 30* 85 •f 4
60 128 + 28 v 5° — 4 *
DDE 10 82 + 34 : 78 “T 7
30 70 + 8 * 48 *r 10*
60 76 + 12 38 + 7 *
DDD 10 111 ■f 85 + 5
30 149 + Ij* ? 33 + 6 *
60 86 + 6 ; ^3 + 9 *
Aldrin 10
ONO 8 7^ *r 4 *
3° 125 + 11* 3 7 + 4 *
60 104 ± 7 63 8 *
Dieldrin 10 110 + 10 82 + 2
3° 154 + 18* 33 -L 2 *
60 95 + 13 67 + 9 *
Table 2.4 In vitro effects of organochlorine insecticides on biphenyl
hydroxylation by’rat hepatic microsomes without preincubation
Results (means + S.E.M. for four animals) are expressed as nmol/mg microsomal 
protein/hr.
Percentage changes relative to control are shown in parentheses.
Test compounds were added to incubation mixture, in 5 Al dimethylformamide, 
at a final concentration of 0.5 mM.
Treatment Biphenyl 2-hydroxylation Biphenvl 4-hvdroxvlation
Control
■ .
7.6 ± 1 147 + 6
DDT
■ ■
7.2 + 1 (-5)
■ .
-
119 ± 4 (-19)
DDD
■
7.1 ± 1 ("8) 118 + 6 (-20)
DDE ■6.6 + 1 (-14) 106 ± 5 (-28)
. " . . ' ■ ■ ■ .
Aldrin
. ' . ' ' ' '
7.0 + 1 (- 8)
' •
96 + 3 (-35)
Dieldrin 10.9 t; 1 (+43) 1 2 3 + 7  (-16)
with rat hepatic microsomes for 30 minutes before the addition of 
biphenyl. The enhancement of biphenyl 2-hydroxylase was concentration 
dependent reaching maximal activity at a final concentration of 2 mM 
for both compounds (Figs. 2.1a and 2,1b). At concentrations lower than 
0.5 mM, DDT had a slight inhibitory effect on the 2-hydroxylase.
Biphenyl 4-hydroxylation was decreased in all cases after preincubation 
with the insecticides.
The effect of different concentrations of phenobarbitone on 
biphenyl hydroxylation in vitro was also investigated after a similar 
preincubation time (Fig. 2.1c). Hydroxylations of biphenyl at both'the
2- and 4-positions were decreased as the concentration of phenobarbitone 
in the incubation mixture was increased.
In vitro enhancement of biphenyl hydroxylation after different periods of 
preincubation with organochlorine insecticides at optimal concentrations
DDT, DDD, DDE, aldrin and dieldrin (2 mM) were preincubated
with rat hepatic microsomes for 10 to 50 minutes before biphenyl
hydroxylase activity was determined. The pattern of enhancement of
biphenyl 2-hydroxylase was similar to that when compounds were preincubated
at a lower concentration. However, DDE' at this concentration had a
slight stimulatory effect on the enzyme after a preincubation period
of 30 minutes (Fig. 2.2). Maximal enhancement by DDT and DDD was
observed after preincubation periods of 20 and 30 minutes respectively,
whereas that of aldrin was after 40 minutes. Dieldrin was the only
compound tested that enhanced biphenyl 2-hydroxylase activity without 
prior preincubation with microsomes (Fig. 2.3). Biphenyl 4-hydroxylase
was significantly decreased by all compounds. The degree of enhancement
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Fig. 2.1 Changes in rat hepatic microsomal biphenyl 2- (a A) and
k- (A— A) hydroxylase activity after a . 30 minute 
preincuhation with varying concentrations of (a) p,p'-DDT
(~b) dieldrin and (c) phenobarbitone 
Mean percentage changes in enzyme activities for four animals are shown.
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Fig. 2.2 Effects of preincubation with organo chlorine insecticides on biphenyl 
hydroxylation by rat hepatic microsomes in vitro 
PjP'-DDT (O— O), p,p 1 -DDD ') and p,p'-DDE (□— □ ) were added to incubation
mixture at a final concentration of 2 mM. Mean percentage changes in enzyme 
activity for four animals are shown.
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Effects of preincubation with aldrin and dieldrin on biphenyl 
hydroxylation by rat hepatic microsomes in vitro
Fig. 2.3
Aldrin (A— A) and dieldrin (&-— a) were added to incubation mixture at a final 
concentration of 2 mM and preincubated at various time intervals. Mean
percentage changes in enzyme activity for four animals, are shown.
in "biphenyl 2-hydroxylation by the insecticides sometimes varied from 
experiment to experiment and in a few cases,, no increase in activity 
could be detected.
Time response relationships of biphenyl hydroxylation in liver microsomes 
from rats given a single injection of p,p*-DDT, dieldrin or 3- 
methylcholanthrene
Effects of p,p’-DDT (200 mg/kg) and dieldrin (45 mg/kg) on a 
number of drug metabolism activities were monitored for various time 
intervals after intraperitoneal administration to rats. For p,p’-DDT, 
increases in the level of biphenyl 2-hydroxylase were apparent after two 
hours and reached a maximum at approximately 4 hours after administration 
(Fig. 2.4). 7-Ethoxyresorufin 0-deethylase activity was similarly
enhanced with very slight inhibition of biphenyl 4-hydroxylase and 
cytochrome P-450 levels. After this initial rise, biphenyl 2-hydroxylase 
and 7-ethoxyresorufin 0-deethylase activities fell to basal levels at 
8 hours with the other parameters remaining unchanged. A second phase 
of increased enzyme activity then occurred. By day 3» biphenyl 2- 
hydroxylase activity was greatly increased with the levels of the other 
parameters also elevated but to a lesser degree.
The general pattern caused by dieldrin was similar, although 
a decrease in enzyme activities occurred 2 hours after administration 
(Fig. 2.5). At 4 hours, both biphenyl 2- and 4-hydroxy lation were 
increased with 7 -ethoxyresorufin activity at its maximum during this 
early phase of stimulation. In either case, this early phase was not 
observed when lower dose levels of 100 mg/kg for DDT and 25 mg/kg for
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-Fig. 2.4 'Effects of a single . ifttrajperitonsal dose, of p,p|-DDT (200mg/kg) 
on various enzyme parameters in male Wistar ■ Albino rats
Results are shown for "biphenyl 2-hydroxylase (A ), * biphenyl 4-hydroxylase ( —
7-ethoxyresorufin 0-deethylase (o---o) and cytochrome P-450 (□**—□).
Mean percentage in enzyme activity (expressed as units per mg protein) for four 
animals are shown. . .
Significant increases in enzyme activity (P<0.05) were detectable after 4 h. 
only for biphenyl 2-hydroxylase.
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Fig. 2.5 Effects of-a single intraperitoneal dose of dieldrin (45mg/kg) 
various enzyme parameters in male Wistar Albino rats
), "biphenyl 4-hydroxylase (Results are shown for "biphenyl 2-hydroxylase (&-— f *■- 
7-ethoxyresorufin 0-deethylase (o---o) and cytochrome P-450 (□■•••□),'
Mean percentage, in enzyme activity (expressed as units per mg microsomal protein) 
for four animals are shown.
dieldrin were used.
With 3-roe'thylcholanthrene, 7-ethoxyresorufin O-deethylase and 
biphenyl 2-hydroxylase activities were significantly increased after 4 
hours and continued to be elevated to a higher level with time (Table 
2.5). 7“Ethoxyresorufin 0-deethylase activity was greatly increased
at day 3*
Effects of various compounds on some hepatic microsomal drug metabolism 
activities in the rat after a single intraperitoneal administration
In light of the results in Figs. 2.4 and 2.5, the initial 
phase of stimulation (4 hours) was compared with the later prolonged 
stimulation of microsomal enzyme activities (3 days) after administration 
of a variety of compounds to rats. Test compounds used were organo chlorine 
insecticides (p,p'-DDT, p,p’-DDD, p,p'-DDE, aldrin, dieldrin, oC-benzene 
hexachloride and ^-benzene hexachloride), chloroform, phenobarbitone and 
carcinogens such as 3-raethylcholanthrene and safrole.
Levels of biphenyl 2-hydroxylase were significantly increased 
with the carcinogens, 3-^e‘thylcholanthrene and safrole, and smaller 
increases were observed for DDT, dieldrin, DDE and chloroform 4 hours 
after administration (Table 2,6). Decreases in biphenyl 4-hydroxylase 
activity were obtained after injection with saf role and If-BHG whilst 
most compounds did not exert a significant effect on this enzyme.
Increased 7-ethoxyresorufin 0-deethylase activity was particularly 
noticeable in the case of 3-methylcholanthrene pretreatment. All the 
other test compounds also appeared to cause a weak stimulatory effect on
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Table 2.6 Changes in various enzyme parameters 4 h after a single
intraperitoneal administration of various chemicals
Results are expressed as percentage increase of enzyme activity (as units 
per mg microsomal protein) + S.E.M. for four animals 4 h after intraperitoneal 
administration. The dose of dieldrin and p,p'-DBT was 45 mg/kg and 
200 mg/kg respectively. * P< 0.05, ** P < 0.01, *** P<( 0 .001.
See 'Methods' for dose levels of other compounds used.
Treatment Biphenyl 4- 
hydroxylase
Biphenyl 2- 
hydroxylase
7-Ethoxyresorufin 
0-deethylase
Cytochrome
P-450
3-Methyl-
cholanthrene 114 + 11 150 + 11*
• - .
: 165 + 4 ** 102 + 2
Safrole
. *** 
6 0 + 3 124 + 14 134 + 7 * 70 + 2
Phenobarbitone ■'■■107+A 9 8 + 5 123 + 12
; ■ ■ 
1 0 3 + 2
PiP'-DDT 98 + 4 1 2 0 + 4 * 129 + 9 * 101 + 4
p,p ' -DDD 1 0 1 + 5 105 + 6 113 + 10 99 + 3
p,p '-DDE 99 + 4 113 ± 1 0 122 + 11 100 + 1
Dieldrin 123 ± 5 * 117 ± 10 1 3 4 + 1 6 * 103 + 6
ot-BHC 112 + 6 108 + 4 1 2 1 + 8 93 + 4
|(-BHC
***
6 6 + 4 97 ± 5 117 + 10 103 + 4
Chloroform 96 + 3 110 + 9 121 + 11 100 + 12
this enzyme at this stage. With the exception of saf role, which caused 
a decrease, cytochrome P-450 levels remained unchanged.
By day 3> after administration, all enzyme parameters measured 
were found to he significantly increased (Table 2.7). However, with 
chloroform, no increase in cytochrome P-450 level was found and biphenyl 
4-hydroxylase activity was only slightly and insignificantly increased. 
Levels of biphenyl 2-hydroxylase and especially 7-e'thoxyresorufin 0- 
deethylase in 3~^e'thylcholanthrene pretreated rats far exceeded all values 
for the other compounds, In general, the stimulatory pattern of 7- 
ethoxyresorufin 0-deethylase"behaves similarly to that of biphenyl 2- 
hydroxylase although with 3-raethylcholanthrene pretreatment, the degree 
of stimulation of the former enzyme far exceeded that of biphenyl 2- 
hydroxylase.
Dose response relationships of biphenyl hydroxylase activities 3 days 
after injection of p,p'-DDT and dieldrin
Both biphenyl 2- and 4-hydroxylase activities, when expressed 
as percentage increases relative to control were dose-dependent and 
accorded with a log dose-response function 3 days after administration 
Of p,p'-DDT or dieldrin (Fig. 2.6 and 2.7). Similar observations were 
obtained for cytochrome P-450 and 7-ethoxyresorufin 0-deethylase levels.
Of particular interest is that the gradient obtained for biphenyl 2- 
hydroxylation in both cases was steeper than any of the other'parameters 
measured.
Effects of 7,8-benzoflavone on in vitro biphenyl hydroxylation
Biphenyl hydroxylase activity in hepatic microsomes from rats
Table 2.7 Changes in various enzyme parameters 3 days after a single
intraperitoneal administration of various chemicals
Results are expressed as percentage increase of enzyme activity (as units per 
mg microsomal protein) + S.E.M. for four animals 3 days after intraperitoneal 
administration.
The dose levels of p,p'-DDT and dieldrin were 200 mg/kg and 45 mg/kg respectively. 
See 'Methods' for dose levels of other compounds used.
Treatment * Biphenyl 4- 
hydroxylase
Biphenyl 2- 
hydroxylase
7-Ethoxyresorufin 
0-deethylase
Cytochrome
P-450
3-Methyl-
cholanthrene 278 + 17 898 + 18 2702 + 45 1 4 7 + 2
Phenobarbitone 165 + 11 241 + 32 138 + 10 128 + 10
p,p'-DDT 211 + 11 271 + 18 124 + 14 200 + 16
p,p'-DDD 208 ± 8 229 + 28. 161 + 9 142 + 5
p,p*-DDE 252 + 17 387 + 22 151 + 16 140 + 9
Dieldrin 286 + 5 521 + 40
•
279 + 2 8
■; ■ ■■ ■ ■
255 + 20
Aldrin 270 + 15
■ ; •
540 + 22 270 + 35 211 + 23
CX-BHC 214 + 16
,
387 + 38 273 ± 45 ; 160 + 12
tf-BHC 209 + 5 368 + 14 334 + 36 139 ± 8
Chloroform 109 + 9 174 + 10 118+18 100 + 13
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Fig. 2.6 Dose-response relationships of biphenyl 2-hydro:xylase (a— A^), 
biphenyl 4-hydroxylase (A-— A) t 7-ethoxyresorufin 0-deethylase 
(O-— O) and cytochrome P-450 (□••••□) 3 days after a single 
.. intraperitoneal injection of p,p'-DDT
Mean percentage changes in enzyme activity for four animals are shown.
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Fig. 2.7 Dose-response relationships of biphenyl 2-hydroxylase (A— -a) 
biphenyl —^hydroxylase (A-— A), 7-ethoxyresorufin O-deethylase
(o-.-o) and cytochrome P-^50 (n □) 3 days after single intraperitoneal
injection of dieldrin .
Mean percentage changes in enzyme activity for four animals are shown
Table 2.8 Effects of ?,8-benzoflavone on in vitro biphenyl hydroxylation
7,8-benzofla.vone (&-naphthoflavone) dissolved in dimethylformamide (l jml) 
was added to the incubation mixture containing hepatic microsomes from saline, 
corn oil, 3-methylcholanthrene (25 mg/kg), DDT (200 mg/kg) or phenobarbitone 
(100 mg/kg) treated rats, giving a final concentration of 10 x 10 J M. 
Compounds were given as a single intraperitoneal administration, and animals 
were killed 3 days after injection. Results are presented as percentages of 
control activity (expressed as nmol/mg microsomal protein) + S.E.M. for four 
animals.'
Treatment Biphenyl 4-hydroxylation Biphenyl 2-hydroxylation
Saline or 
corn oil
3-Methyl-
cholanthrene
DDT
Phenobarbitone
95 ± 6
48 . + 4
86: + 6
87 + 1
88 + 12
33 + 7
74 t 6
90 + 5
pretreated with corn oil, 3-wethylcholanthrene, DDT or phenobarbitone 
was determined in the presence of the cytochrome P-448 inhibitor, 7,8- 
benzoflavone (10 x 10"^ M).
Both biphenyl 2- and 4-hydroxylase activities were significantly 
decreased in the 3-methylcholanthrene pretreated group. Only slight 
decreases in biphenyl hydroxylation were observed in the other animal 
groups (Table^ 2.8).
DISCUSSION
Hydroxylation of biphenyl at the 2- or 4- position by liver 
microsomes is thought to reflect the different enzyme specificities of 
cytochrome P-450 and P-448 (Burke and Mayer, 1975). Biphenyl 4-hydroxylase 
activity is inherent in both cytochrome P-450 and P-448 whereas hydroxylation 
at the 2-position appears to proceed solely via cytochrome P-448 (Atlas 
et al., 1975;,?Atlas and Nebert, 1976). Cytochrome P-448 is selectively 
enhanced by pretreatment of animals with polycyclic hydrocarbons such as
3-methylcholanthrene and other carcinogens (Alvares et al., 1967; Mannering, 
1971) and similarly, enhancement of biphenyl 2-hydroxylase appears to be 
a specific property of carcinogens (Parke, 1977).
In the present study, DDT, DDE, DDD, aldrin and dieldrin enhanced 
biphenyl 2-hydroxylase activity to varying degrees after in vitro 
preincubation with,hepatic microsomal fractions from three mammalian 
species. The extent of enhancement was, in most cases, dependent on 
the preincubation period possibly reflecting the time required for metabolic 
activation of the test compounds. Metabolism of carcinogens to an active 
electrophilic or free radical intermediate by microsomal oxidation is 
generally accepted as a pre-requisite for chemical carcinogenesis (Glayson 
et al., 19715 Garner et al., 1972; Huberman et al., 1972). McPherson et 
al. (1974) alsb showed that metabolism by hepatic microsomes in the presence 
of an NADPH-regenerating system was necessary for carcinogens to produce 
their in vitro enhancing effect on biphenyl 2-hydroxylase. Therefore, 
the test compound undergoes microsomal metabolism during the preincubation 
period. However, it is worth noting that after the addition of biphenyl, 
a ten minute reaction was allowed and the test compound is likely to be 
further metabolised to some extent during this period.
Dieldrin appeared to be an exception in that no prior metabolism ; 
was necessary for the elevation of biphenyl 2-hydroxylase activity 
indicating that the compound itself was able to elicit such a change.
Such enhancement, however, disappeared or became depressed with longer 
preincubation, presumably due to conversion of dieldrin to a less active 
metabolite. This gradual decrease in enhancement with time appears to 
occur with all the other compounds examined. Aldrin may also exert its 
effect on the*biphenyl system after conversion to dieldrin. Epoxidation 
of aldrin and dieldrin itself, by microsomal metabolism has previously 
been demonstrated (Wong and Terriere, 1965; Krampl and Hladka, 1975;
Ghiasuddin and Menzer, 1976; Oberholser et al., 1977).
In vitro microsomal metabolism of DDT to DDD and a phenolic 
metabolite by rat hepatic microsomes has been reported (Morello, 1965)4 
although many papers reported more rapid conversion of DDT to these 
products under anaerobic or reduced conditions (Hassall, 1975; Miskus et 
al., 1965; Bunyan et al., I966). Recently, the occurence of a carbene 
complex during reductive reactions between DDT and iron porphyrins has 
been demonstrated (Mansuy et al., 1978). Preliminary spectral binding 
studies with DDT, as well as DDD, in reduced hepatic microsomes showed 
the development of a 456 nm peak (data not shown). This appears to be 
analogous to the reported formation of carbene complexes by polyhalogenated 
compounds with reduced cytochrome P-450■ (Wolf et al., 1977; Mansuy et al., 
197^). The inability of microsomes to. metabolically activate the insecticide 
in the Ames test has recently been shown (Rickard et al., 1978). Only 
a small percentage of the introduced DDT was found to be metabolised by 
the microsomal supernatant present in the system. This may explain why 
DDT gives a negative result in the test (Marshall et al., 1977).
The inhibition of biphenyl 4-hydroxylase activity by organochlorine 
insecticides and various compounds as reported by McPherson et al.(1974) 
possibly indicates metabolic competition between the enzyme substrate, 
biphenyl, and test compounds (or their metabolites) since most of the 
latter are metabolised through the same microsomal mixed-f unction oxidase 
system. Carcinogenic compounds, used at high concentrations in vitro, 
may also compete for biphenyl 2-hydroxylation due to their high affinity 
towards cytochrome P-448 (Kuntzman, 1969). If competition
occurs, the observed in vitro increase in biphenyl 2-hydroxylase activity 
would be lower than the actual degree of enhancement.
The weakly positive results obtained with the DDT compounds in 
the biphenyl test require careful interpretation in view of the uncertainty 
.121 vitro metabolism and the poor reproducibility of the in vitro 
stimulation of biphenyl 2-hydroxylation. Furthermore, no species
difference in enhancement was observed although the biological activity 
of DDT, in terms of hepatocarcinogenicity, varies markedly between rats 
and mice (Terracini et al., 1973; Rossi et al., 1977).
McPherson et al. (1974) obtained an over two fold enhancement 
in biphenyl 2-hydroxylase activity in vitro with various carcinogens, and 
insignificant increases for non-carcinogens. The results obtained here 
with organochlorine insecticides were less defined since the significance 
of the relatively small increases observed is uncertain. This is 
consistent with the equivocal results obtained in in vivo carcinogenicity 
studies with compounds such as DDT. Ashby et al.(l978) have termed 
chemicals such as DDT and chloroform together with saccharin as epigenetic 
carcinogens in contrast to 'unequivocal carcinogens' such as dimethyl- 
nitrosamine whose interaction with DNA is thought to be central to their 
biological activity. The development of in vitro test systems capable
of detecting such 'epigenetic* carcinogens is therefore an important 
problem. On the other hand, the positive results obtained with a 
number of carcinogens by McPherson et al.(1974) have been called into 
question since some of the test compounds were found to give rise to 
fluorescent metabolites which lead to false-positives in the biphenyl 
test (see later chapter). Hence, a comparison of results obtained here 
and previous findings may not be valid unless the stimulation of biphenyl 
2-hydroxylase* can be confirmed by alternate techniques.
Inhibition of biphenyl hydroxylation by 7 > 8-benzoflavone 
indicated the similarity between DDT and phenobarbitone induction as has 
been shown by other workers (Wright et al., 1972; Vainio, 1975). The 
significant decrease in biphenyl 4-hydroxylase activity in 3-methyl- 
cholanthrene pretreated rats agreed with the finding that considerable 
activity of the enzyme proceeded via cytochrome P-448 in similarly 
treated animals (Atlas and Nebert, 1976).
Experiments with 3>^“benzpyrene and safrole indicated an initial
increase in biphenyl 2-hydroxylase activity 4 hours after intraperitoneal
administration (McPherson et al., 1976). A good correlation between
this early phase of stimulation, which was not due to de novo protein
synthesis (McPherson et al., 1976) and in vitro stimulation by the same
compounds was obtained by the workers. DDT and dieldrin also elicited
such a change during this phase, but the increase in biphenyl 2-
hydroxylation as with other chlorinated compounds tested was small as
compared to the greater elevation caused by 3-roethylcholanthrene. The
degree of stimulation is related to the dose level employed, but since 
this is already near the LD^q for rats, higher levels could not be given.
This reflects the requirement for a high concentration of organochlorine 
insecticides to be present both in the in vitro and in this early in vivo 
state to elevate biphenyl 2-hydroxylase activity.
In this study, there is a general lack of correlation of results 
obtained in the biphenyl test with those from in vivo carcinogenicity 
studies. For example, cx-BHC has been demonstrated to be carcinogenic 
in rats whilst &-BHC (lindan^)<gave negative results (Nagasaki et al.,
1972; Ito _et al., 1975); but no difference in the stimulation of biphenyl 
2-hydroxylase activity was observed for those two compounds when administered 
to rats. Furthermore, DDE which has been suggested as being the proximate 
carcinogen of DDT for it is found as a metabolite in mice in which DDT is 
carcinogenic (Gingell, 197&), d-icL not appear to stimulate biphenyl 2- 
hydroxylation above that produced by DDT or DDD in the iu vitro biphenyl 
test. However, a significantly higher-stimulation of biphenyl 2-hydroxylase 
activity was obtained with DDE as compared with the other two compounds 
3 days after a single i.p. injection. These results, therefore, raise doubt 
to the validity of assessing for carcinogenicity by such means.
With increasing concentrations of a compound administered, a 
greater ratio of 2- to 4-hydroxylation (when compared as percentage over 
control) can be obtained 3 days after the injection. This is consistent 
with findings that stimulation of biphenyl 2-hydroxylase activity in vitro 
is also concentration dependent. Since biphenyl 2-hydroxylation appears 
to be elevated higher than biphenyl 4-hydroxylation with increasing dose 
levels, it is necessary to carefully select the dose level of a test 
compound in order to obtain a valid comparison with other test chemicals.
The present study has dealt only with a single intraperitoneal administration 
of the test compound. However, repeated administration of a chemical,, 
particularly if it is toxic after prolonged treatment may result in an
induction pattern differing from one that is less hamful to the animal, 
and would provide better differentiation between compounds.
CHAPTER THREE
INTERFERENCE OF FLUORESCENT METABOLITES WITH THE 
DETERMINATION OF BIPHENYL 2-HYDR0XYLATI0N IN THE 
IN VITRO BIPHENYL TEST FOR CHEMICAL CARCINOGENS
INTERFERENCE OF FLUORESCENT METABOLITES WITH THE DETERMINATION OF
BIPHENYL 2-HYDR0XYLATI0N IN THE IN VITRO BIPHENYL TEST FOR CHEMICAL
 ^ CARCINOGENS
INTRODUCTION
Biphenyl has been used as a fungistat on citrus fruits.
It possesses relatively low order of mammalian toxicity, and the 
quantities consumed as residues in fruits are innocuous although human 
poisoning was reported in a fruit paper production plant (Hakkinen et 
sT., 1973). The metabolism of this compound has been extensively 
examined in various animal studies. 4-Hydroxybiphenyl Is the major 
metabolite of biphenyl in the rat, hamster and guinea pig, and minor 
products include 2-hydroxybiphenyl, 3“bydroxybiphenyl, difeydroxy-, tri­
hydroxy-, hydroxymethoxy- and dihydroxymethoxy-biphenyls (Haig and 
Ammon, 1970 > 1972; Raig et al., 1976; Meyer and Scheline, 1976; Meyer 
et_al., 1976, 1976a; Meyer, 1977). In some marine organisms, however,
2-hydroxybiphenyl was found to be the most prominent metabolite (Meyer 
and Bakker, 1977)•
The selective enhancement of biphenyl 2-hydroxylase by carcinogens 
both in vivo and in vitro was described in the previous chapter. It 
was suggested that the enhancement of biphenyl 2-hydroxylase can provide 
a basis for a preliminary in vitro screening system for testing potential 
chemical carcinogens (McPherson et al., 1974a).
Determination of the biphenyl hydroxylase activity involves 
separation of the hydroxybiphenyls from the parent compound followed
by fluorimetric determination of the 2- and 4-hydroxybiphenyl. The 
two hydroxybiphenyls can be individually determined, as the 2-isomer 
shows excited-state ionization, whereas the 4-isomer does not (Bridges 
et al., 1965). Many carcinogens, such as 3»4-benzpyrene, 3-methyl- 
cholanthrene and safrole are highly fluorescent, and although these 
compounds are not themselves extracted along with the hydroxybiphenyls, 
their hydroxylated metabolites formed during the microsomal incubation 
may be extracted into the alkaline fraction and thus interfere with the 
fluorimetric assay of the hydroxybiphenyls.
Previous work by McPherson et al.(l976) showed marked increases 
in the biphenyl 2-hydroxylase activity with the carcinogens, safrole,
3-methylcholanthrene and 3>4-benzpyrene in the in. vitro biphenyl test. 
Studies were therefore carried out here to ascertain if the above compounds 
do give rise to metabolites that are likely to interfere with the 
fluorimetric assay.
METHODS AND MATERIALS
Male Wistar Albino rats (150-200 g) were used, s were
intraperitoneally administered with phenobarbitone-sodium in 0.9^ (W/v) 
NaCl solution (1.0 ml per animal) at 75 mg/kg per day for three
consecutive days, 3-Methylcholanthrene in corn oil (l.O ml per animal) 
was administered intraperitoneally to animals
mg/kg as a sipgle dose. Identical volumes of either c o m  oil or saline
were given to control animals as appropriate. Rats were killed 24 hours 
after the last injection.
livers immediately removed. Hepatic microsomal suspensions were 
prepared as previously described in Chapter 2. Protein was determined 
by the method of Lowry et al.(l95l) using bovine serum albumin as 
standard.
Safrole, 3-methylcholanthrene and 3»4-benzpyrene were dissolved 
in dimethylformamiae (DMF) to give a final concentration of 0.5 mM in the 
incubation mixture. 5 >ul of DMF was the maximum volume added. These 
compounds were incubated with the microsomal suspension (lmg protein/ 
ml) in the presence of magnesium chloride (0.05 mii) and an NADPH- 
regenerating system (glucose 6-phosphate 15>umol; NADP 2 yumol; glucose 
6-phosphate dehydrogenase 2 units) in a total incubation volume of 2 ml 
at 37°C. The enzymic reaction was stopped at various time intervals 
as required, and the metabolites were extracted and determined by using 
the method as described in Chapter 2, In experiments where GO was employed, 
the gas was gently bubbled into the incubation mixture for 1 minute before 
the start of incubation period.
The animals were killed by cervical dislocation, and their
RESULTS
The incubation of safrole with liver microsomal suspension 
from untreated control rats, in the presence of an NADPH-regenerating 
system, resulted in an increase of fluorescence at 338 mm which reached 
a maximum after 60 minutes (Table 3*1A). At 415 nm, which is employed 
for the measurement of the amount of 2-hydroxybiphenyl, the metabolite(s) 
of safrole was also shown to fluoresce but to a lesser extent than that 
at 338 nm. However, when compared to the normal fluorescent values 
obtained from a biphenyl assay, the readings due to the metabolite(s) 
of safrole are significantly greater in either wavelength. Safrole 
itself is also fluorescent under these conditions, as shown when the 
enzymic reaction was terminated at zero time.
When microsomal suspension from phenobarbitone-pretreated rats 
was used, the fluorescence readings at both wavelengths were higher 
for a similar incubation period than when control microsomal suspension 
was used (Table 3,13). The increases were even more marked after 3- 
methylcholanthrene pretreatment. In both cases, the reaction was 
greatly inhibited in the presence of carbon monoxide.
Similar observations were obtained with the carcinogens, j- 
methylcholanthrene and 3,4-benzpyrene. These two compounds differed
from safrole in that they did not show any fluorescence in the blank 
samples. Also, their metabolites only fluoresce at 415 nm, which is 
used for the determination of the 2-hydroxybiphenyl (Tables 3.2A). 
Phenobarbitone pretreatment to> rats resulted in slight depression of the 
microsomal metabolism of these two carcinogens (Table 3*2B and 3*3) 
whereas pretreatment with 3~^e'thylcholanthrene resulted in higher 
fluorescence at 415 nm.
Table J.lk Fluorescence from safrole alone in the biphenyl test
for chemical carcinogens
Safrole (0.5 mM) was Incubated with rat liver microsomal suspension(untreated) in 
the presence of an NADPH-fegenerating system for various periods of time.
The incubation mixtures were extracted as described in 'Methods', and 
the fluorescence at (a) 338 nm (excitation 275 nm) and (b) 415 nm (excitation 
295 nm) was determined. Results are expressed as units of fluorescence 
per mg microsomal protein. Blank values were obtained by termination 
of enzymic reaction at zero time.
* normal biphenyl assay without safrole.
Incubation time (min) Units.of fluorescence
a ■ b v.
; 10* 0.5 0.1
V -  0 ■ 0.7 0.1
10 2.1 • 0.2
20 3.3 0.4
30 ' 3.9 :.V. 0.4
40 ; 4.3 0.6
60 4.6 0.6
80 4.7 0.6
Table 3.IB In vitro metabolism of safrole by hepatic microsomes
from control, .phenobarbitone- and 3-methylcholanthrene 
* treated rats
Safrole (0.5 mM) was incubated with rat hepatic microsomal suspensions 
for 10 minutes in the presence of an NADPH-regenerating system.
The same protein concentration was used throughout.
Fluorescence w^ is determined at (a) 338 nm (excitation 275 nm) as for
4-hydroxybiphenyl, and (b) 415 nm (excitation 295 nm) as for 2 -hydroxy­
biphenyl. * reaction mixture flushed with CO.
Treatment Units of fluorescence per mg microsomal protein 
per 10 minutes
a b
Blank 0.7 0.1
Control 3.2 (1.0)* 0.4 (0.1)*
Phenobarbitone 5 5.8 (0.8)* 0.6 (0.2)*
3-Methylcholanthrene 25.3 - (4.1)* .. 2 .4 (0.8)*
Table 3»2A Fluorescence from metabolites of 3>4-benzpyrene or
3-methylcholanthrene alone in the biphenyl test for
carcinogens
3»4-benzpyrene (0.5 mM) or 3-methylcholanthrene (0.5 mM) was incubated 
with rat liver microsomal suspension in the presence of an NADPH-regenerating 
system for various periods of time.
The incubation*mixtures were extracted, and the fluorescence at 415 nm 
(excitation 295 nm) was determined.
Results are expressed as units of fluorescence per mg microsomal protein. 
Blank values were obtained by termination of enzymic reaction at zero time.
Incubation time (min) Fluorescence at 415 nm
3»4-benzpyrene 3-methylcholanthrene
0 0.0 0.0
10 1-? • 0.8
.V; 20 1.6 1.3
30 1.7 1.4
40 1.6 1.3
50 1.7 1.4
Table 3.2B In vitro metabolism of 3»4-benzpyrene by hepatic microsomes 
from control, phenobarbitone- and 3-methylcholanthrene- 
treated rats
3»4-Benzpyrene (0.5 mM) was incubated with rat hepatic microsomal suspensions 
for 10 minutes in the presence of an NADPH-regenerating system.
The same protein concentration was used throughout.
Fluorescence was determined at 415 nm (excitation 295 nm) as for 2- 
hydroxybiphenyl.
* reaction mixture flushed with CO.
Treatment Units of fluorescence per mg microsomal 
protein per 10 minutes
Blank 0.0
Normal (0.6)*
Phenobarbitone 0.9 (0.4)*
3-Methylcholanthrene 2.1 (o.?)*
Table 3-3 In vitro metabolism of 3-methylcholanthrene by hepatic
microsomes from control, phenobarbitone- and 3-methyl- 
cholanthrene treated rats
3-Methylcholanthrene (0.5 mM) was incubated with rat hepatic microsomal 
suspensions for 10 minutes in the presence of an NADPH-regenerating system. 
The same protein concentration was used throughout.
Fluorescence was determined at 415 nm (excitation 295 nm) as for 2- 
hydroxybiphenyl.
* reaction mixture flushed with CO.
- Treatment Units of fluorescence per mg microsomal 
protein per 10 minutes
Blank 0.0
Control 0.7 (0.2)*
Phenobarbitone 0.5 (0 .2)*
3-Methylcholanthrene i.7 (0 ..5)*
DISCUSSION
The three carcinogens safrole, 3-methylcholanthrene and 3>^- 
benzpyrene gave rise to fluorescent products when incubated with hepatic 
microsomal suspensions in the presence of an NADPH-regenerating system. 
Pretreatment of rats with 3-methylcholanthrene, but not phenobarbitone, 
caused a marked elevation of activity towards the metabolism of these 
compounds. ?^his is in agreement with previous findings that benzpyrene 
hydroxylase activity was more markedly enhanced when rats were pretreated 
with the polycyclic hydrocarbon than with phenobarbitone (Kuntzman et al., 
19^9; Alvares _et al., 1970; Vainio, 197^)• The metabolism of the above 
compounds was inhibited to a great extent by the presence of carbon 
monoxide. It appears therefore that the reaction is mediated through 
cytochrome P-450 or cytochrome P-448, as in 3-methylcholanthrene pre­
treated rats (Cooper et al., 1965; Murphy et al., 1969).
The metabolites of these compounds were extracted into the 
alkaline layer in the assay, and the intensity 01 their fluorescence 
gave an indication of the amount present and hence the rate of metabolism 
by the various microsomal suspensions. The finding of the presence of 
fluorescent products is not too surprising since benzpyrene hydroxylase 
activity may be determined by a fluorimetric assay (Nebert and Gelboin, 
1968). The wavelengths used for excitation and fluorescence were 39^ 
nm and 522 nm respectively, whilst the determination of 2-hydroxybiphenyl 
employs an excitation wavelength of 295 nm and a fluorescence wavelength 
of 415 nm. Although the wavelength optima for the two determinations 
do not correspond, overlapping of their fluorescence spectra occurs 
thus giving rise to interference in the assay.
Safrole differed from the other two compounds in that at 338 nm, 
the wavelength used for the determination of 4-hydroxybiphenyl, its 
metabolite(s) was highly fluorescent whilst metabolites of 3-methyl­
cholanthrene and 3»^-benzpyrene did not fluoresce at this wavelength.
It also appears that safrole itself is extracted in the alkaline layer 
since fluorescent readings were obtained in samples that did not contain 
the NADPH-regenerating system. Although the fluorescence produced by
safrole and its metabolite(s) would interfere with the estimation of 
*
4-hydroxybiphenyl formed by enzymic reaction, McPherson et al.(197^) 
actually reported a decrease in the activity of this enzyme after 
preincubation in vitro with safrole. This previous finding may be due 
to the competitive inhibition of biphenyl 4-hydroxylase by safrole 
(Crampton et al., 1977) since the weak hepatocarcinogen is known to 
form a tight complex with cytochrome P-450 (Franklin, 1971; Elcombe et al., 
1975; Ullrich, 1977).
The experiments described indicated that various carcinogens 
gave rise to fluorescent products that are extracted along with the 
hydroxybiphenyls. Hence, interference occurs to varying degree, depending 
on the fluorescent characteristics of the compound, with the determination 
of biphenyl 2-hydroxylase activity and could give rise to false-positives 
in the biphenyl test. It would be difficult to set up appropriate 
blanks for these experiments since many of the test compounds and biphenyl 
are metabolised by the same cytochrome P-450 and competition for the 
enzymic reactions would occur. It is necessary to check all previous 
positive findings in order to assess the validity of the in vitro biphenyl 
test, and to confirm in vivo experiments performed by Creaven and Parke 
(1966) to show that selective enhancement of the biphenyl 2-hydroxylase 
activity occurs by pretreatment of animals with carcinogens. Techniques
available, such as gas-liquid chromatography (Raig and Ammon, 1976; 
Billings and McMahon, 1978) or high-pressure liquid-chromatography 
(Burke et al., 1977)> which are capable of separating 2-hydroxybiphenyl 
from hydroxylated metabolites-arising from the test compounds are useful 
alternatives to be employed for such means.
CHAPTER FOUR
STUDIES ON LIVER RESPONSE IN RATS DURING 
CHRONIC ADMINISTRATION OF DDT
STUDIES ON LIVER RESPONSE IN RATS DURING CHRONIC ADMINISTRATION OF DDT
INTRODUCTION
The biological activity of DDT in mammals has been widely 
investigated and considerable attention has been directed to assessing 
its carcinogenic potential. Although several reports have failed to 
provide any eyidence of carcinogenicity (Deichmann et al., 1967; Ortega, 
I966; Ottoboni, I969)> the induction of tumours, particularly in the liver, 
has been associated with DDT administration in a number of studies.
Fitzhugh and Nelson (19^7) observed 'low grade' tumours and adenomatous 
hyperplasia of the liver in rats exposed to high dietary DDT over 400 
ppm, and more recently, Rossi et al. (1977) found a significant increase 
in liver tumours during a life-span study when Wistar Albino rats were 
given 500 ppni DDT in the diet. The hepatic alterations, which occurred 
late in life in nearly half of the experimental animals, were classified 
as neoplastic nodules. These nodular formations posed the possibility 
of progression to hepatocellular carcinoma (Squire and Levitt, 1975)•
The evidence of carcinogenicity of dieldrin, as with DDT, is 
conflicting and most of the positive results were obtained in experiments 
with mice. However in rats, this cyclodiene insecticide was found to 
cause the development of hypoactive, hypertrophic smooth endoplasmic 
reticulum (HHER). There was an abundance of smooth endoplasmic 
reticulum but this was not associated with elevated levels of drug- 
metabolising enzyme activity. This HHER occurred when dieldrin was 
repeatedly given to animals at a high dose level of 5 mg/kg (Hutterer et
Three stages of response were suggested to explain the observed 
phenomenom (Hutterer -et'.al., 19&9) • The first stage, characterised by a 
general increase in microsomal drug-metabolising enzyme parameters such as 
cytochrome P-450, aniline hydroxylase, p-nitroreductase and smooth endo­
plasmic reticulum, was that of the 'induction' phase. A 'steady state' 
was then reached in the second stage. In the third stage, that of 
'decompensation', the activity of drug-metabolising enzymes started to 
decrease while cytochrome P-450 levels were maintained with the smooth 
endoplasmic reticulum appearing just as abundant as in the previous stages. 
The 'decompensation' phase was considered to represent a transition from 
adaptation to liver injury and could be used as a sensitive indicator of 
toxicity before light microscopic changes are recognizable (Hutterer et al., 
1968). The phases of induction and steady state represent usually a 
beneficial condition as detoxication of many potentially damaging agents 
is accelerated. In the state of decompensation, increased susceptibility 
to drugs exists (Hutterer et al., 19&9).
The development of HHER was later confirmed by Stevens et al. 
(197?) in both male and female rats, although it was noted that the effect 
did not appear in all their chronic feeding experiments. These.workers, 
however, suggested that HHER may result from qualitative changes in the 
dieldrin-induced cytochrome P-450 rather than to a decompensation response.
If DDT ultimately leads to the appearance of liver tumours in 
rats, some morphological or biochemical changes must precede such an event. 
These hepatic changes have been examined with other compounds which, like 
DDT, produce liver tumours only after long-term administration at high 
doses, e.g. safrole and Ponceau MX (Crampton et al., 1977). DDT manifests
changes in the liver similar in some respect to that produced "by dieldrin. 
For dieldrin, Hutterer et al. (1968) have provided a possible "basis for 
its hepatoxicity in terms of the development of HHER. Therefore, in 
the present project, various biochemical and morphological parameters 
were examined during chronic administration of DDT (250 ppm and 500 ppm) 
to male rats. Histological and ultrastractural studies were made to 
detect any liver injury, and these were related to the levels of induced 
microsomal eri%yme activities. Insecticide residues accumulated in the 
liver and microsomes of the test animals were also measured sequentially 
to determine if the presence of DDT did affect the extent of enzyme 
induction. In addition, histochemical techniques were employed to detect 
possible liver damage which may be present without any observable hepato­
cellular damage (Grasso _et al., 197^).
MATERIALS AND METHODS
Materials
Cytochrome c (Type IIA from horse heart), NADH (disodium salt), 
ft-mercaptoethylamine, cytidine 5,-raonophosphoric acid (CMP, disodium 
salt) and florisil (magnesium silicate, 60/100 PR) were obtained from 
Sigma Chemical Co., London. BDH Chemicals Ltd., Poole,supplied the 
following chemicals: p-aminophenol, p-nitrophenol, anhydrous sodium 
sulphate (AR), lead nitrate (AR) and glycerol jelly (microscopic reagent). 
Aniline hydrochloride was purchased from Aldrich Chemical Co. Ltd.,
Gillingham, and hexobarbitone from May and Baker Ltd., Dagenham.
[^C]Cholesterol was obtained from the Radiochemical Centre, Amersham, 
Buckinghamshire. Chemicals and materials used for electron microscopic 
work were purchased from TAAB Laboratories, Reading. Other chemicals 
not mentioned may be found under 'Materials and Methods1 section in Chapter 2.
Experimental animals were maintained on powdered diet for 
rodents (Lab. Diet 2 from Spratt's Laboratory Service). Test diets 
contained p,p'-DDT (99*$) and were prepared by evenly mixing appropriate 
amounts of finely ground DDT powder with the powdered food.
Animals
Male Wistar Albino rats (50-80 g body weight) were divided into 
three main groups and kept in plastic cages under controlled temperature 
and humidity. Food and water were provided ad libitum to all animals.
Group I animals was given powdered diet and water only and served as 
control groups. Animals in Groups II and III received water and diet 
containing 250 ppm and 500 ppm DDT respectively. Details of groupings 
for the study are shown in Table 4.1.
TABLE 4vl
Groupings of animals for the-s t u d y  0f the chronic effect of D D T  on 
male Wistar Alhino rats •.
GROUPS n6. of
ANIMALS 
PER GROUP
TIME ON 
TREATMENT
: PARAMETERS 
INVESTIGATED
I 10 days; Microsomal protein; cytochrome 
cytochrome P-450; NADPH-cytochrome 
c reductase; biphenyl 2- and 4-II
: " 6 ^ weeks;
& 8 weeks; hydroxylases; p-nitroanisole 0-
. HI' 16 weeks.
demethylase; binding spectral 
studies; insecticide residue 
levels.
I 10 days; 7-Ethoxyresorufin 0-deethylase;
11 4 ^ weeks;
cholesterol 70  ^-hydroxylase; 
histology; histochemistry;
.■-.V.. &
III
8 weeks. electron microscopy. ■
I All parameters as shown in
II
&  ^
h i
k 32 weeks ’Result', section at week 32.
For spectral binding studies, rats were pretreated with a) 
phenobarbitone (80 mg/kg) in 0.9$ (W/v) NaGl solution (0.5 ml/animal) 
for 3 days and killed 24 hours after last treatment, b)p,p'-DDT in corn 
oil (160 mg/kg; 1 ml/animal) for 3 days and killed 72 hours after last 
treatment, or c) 3-wethylcholanthrene in com oil (15 mg/kg; 1 ml/animal) 
for 3 days and killed 24 hours after final dose. All three compounds 
were administered by daily intraperitoneal injections.
Methods for the determination of drug-metabolizing enzyme activities
The estimation of cytochrome P-450 content and 7~ethoxyresorufin 
0-deethylase activity in microsomal suspensions was performed as outlined 
in Chapter 2. Unless otherwise stated, incubations were carried out at 
37°C in a shaking water bath (80 cycles/min).
Biphenyl 2- and 4- Hydroxylases
Microsomal supernatant (10,000 g) was used in these experiments.
The incubation mixture consisted of the following:
TEST (ml) BLANK (ml)
Tris-HCl buffer (0.05M; pH 8.1) • • • • 0.50 0.50
MgGl2 (0.05M) •• *v 0.25 0.25
NADP (3mM) ;*• 0.50 0.50
Microsomal supernatant (23%) * ’ ■ ' 0.50 0.50
Biphenyl 12 mM in 2^(V/V) Tween 80 •• 0 25 0.25
(addition after incubation in blank tubes) * *
Total incubation volume: 2.00 2.00
* This was further diluted (l:l) with 1.15$ KC1 for DDT-treated animals
due to high protein concentration.
The extraction procedure and estimation of products formed 
were carried out as detailed in Chapter 2 after allowing for a reaction 
period of 15 minutes. Appropriate blanks and standards, in duplicate 
as with test samples, were also run through the assay (see Chapter 2).
Aniline Hydroxylase 
¥
p-Aminophenol is formed as a major product when aniline is 
metabolized by rat hepatic microsomes and its quantitative measurement, 
based on the method by Guarino et al. (19°9)» provides a means of measuring 
the rate of aniline metabolism.
The incubation system employed was as follows:
TEST (ml) BLANK (ml)
Tris-HCl buffer (0.3M; pH 7.6) " • • 0.25 0.2 5
MgCl9 (0.05M) •• 0.25 0 .2 5
NADP (8mM) •*0.25 0.25
Glucose 6-phosphate (80mM) V* 0.25 0.2 5
Aniline hydrochloride (40mM) * * • * 0.50 0 .50*
Microsomal supernatant (25$) ** ;• ’ 0.50 0.50
Total incubation volume: 2.00 2.00
* indicates addition after incubation.
An incubation time of 15 minutes was used since longer incubation 
results in the disappearance of p-aminophenol (Hazel, 1972). The reaction 
was terminated by the addition of solid NaCl (about 0.8 g) followed by 
10 ml of peroxide-free ether containing 1,5$ (V/v) isoamyl alcohol.
After a 20 minute extraction period, 8 ml ether aliquots were withdrawn 
 and added to k ml of alkaline phenol*. The tubes were then returned to
the rotary shaker and extracted for a further 10 minutes. The blue-
coloured complex thus formed was measured at 620 nm in a Cecil-272 •
spectrophotometer after the tubes were allowed to stand for 30 minutes. 
Appropriate blanks and standards (0.1/imol p-aminophenol in 0.IN HCl) 
were carried out through the same procedure. All Incubates were carried 
out in duplicate.
* Freshly prepared solution of 0.3M tripotassium orthophosphate containing 
1% C M  phenol.
p-Nitroanisole O-Demethylase
The assay employed was that of Lake (197^)» which was modified 
from methods of Netter and Seidel (196 )^, Gilbert and Golberg (1963) and 
Peters and Fouts (1970). The measurement was by estimation of the formation of
4-nitrophenol, which gives a yellow colour under alkaline conditions.
The incubation mixture consisted of the following:
TEST (ml) BLANK (ml)
Potassium phosphate buffer 0.75 0.75
0.25 0.25
Microsomal supernatant (2%)
p-Nitroanisole (800 mM) 
in dimethylformamide
0.50
5 /11
0.50
5 >61*
NADP
Glucose 6' 
phosphate
(5mM)
(60mM) 0.25
0.23 O .23
0.23
Approximate incubation volume 2.00 2.00
* indicates addition after incubation.
Incubation was carried out for 15 minutes after the addition 
of substrate. Solid NaCl (about 0.8 g) and 10 ml of diethyl ether 
containing 1.5% iso amyl alcohol were then added to terminate the reaction 
The tubes were extracted on a rotary shaker for 20 minutes, and 8 ml of 
the ether phases were removed into clean tubes containing 3 ml of 0.IN 
NaOH. Another 20 minutes of extraction was allowed after which the 
ether layers were aspirated off.
The absorbance of the yellow coloured aqueous layer was measured 
at 420 nm in a Cecil-272 spectrophotometer. Standard tubes containing 
O.l^mol p-nitrophenol were carried out through the same procedure. All 
incubates were carried out in duplicate.
NADPH-cytochrome c Reductase
The method was a modified version of that described by Williams 
and Kamin (1962), which depends upon the pronounced absorption maximum 
of reduced cytochrome c at 550 nm.
The following was set up in a pair of cuvettes:
TEST (ml) BLANK (ml)
Potassium phosphate buffer ,, 1 n 1 R
(0.05M; pH. 7 .6 with ImM Kao :
Cytochrome c (0.ImM) • • 1.0 1.0
Microsomal suspension (25%) -  '* 0.2 0.2
NADPH (30mM)* * .** 0.1 -
Total volume: 3.0 3.0
* addition to initiate reaction.
A baseline was drawn with both the cuvettes in place prior to 
adding NADPH to the test sample in a Pye-Unicam SP-1800 recording 
spectrophotometer. NADPH was then added and the reaction was followed 
at ambient temperature for approximately 2 minutes when the rate of 
reaction was linear.
Cytochrome br ------------
The estimation of cytochrome b^ content was based on the 
method of Omura and Sato (1964) measuring the difference spectrum 
of the reduced cytochrome against its oxidised form.
Microsomal suspension was diluted with 0.1M potassium phosphate
buffer pH 7.4 to an approximate protein concentration of 2 mg/ml.
2.5  ml of the diluted solution was added to each of a pair of matched
cuvettes, followed by 0.1 ml of NADH (l mg/ml) to the sample cuvette.
A difference spectrum was then recorded between 390 nm and 450 nm in a
Pye-Unicam SP-1800 dual beam spectrophotometer. The quantity of
cytochrome b^ was determined from the absorbance difference (410 nm
— 1 ■ — 1'and 426 nm) employing an extinction coefficient of 171 cm mM~ . ■ ;
Cholesterol 7fl~Hydroxylase
For this assay, liver was homogenised in ice-cold Tris-sucrose 
buffer (0.1M Tris-HCi 0.25M sucrose; pH 7.^) to give a 20% homogendte 
employing a Tri-R variable speed drill (speed setting at 3). ' The 
homogenate was then centrifuged at 18,000 g (12,900 r.p.m. for 20 minutes) 
in a M.S.E. H.S. 18 centrifuge with an 8 X 50 ml angle head rotor,.
The incubation system consisted of the following:
0,1M Potassium phosphate buffer, pH 7 • 4 
containing 0.5/iCi [4--^c]cholesterol 
solubilised in Tween 80 (1.5 mg/ml of 
incubate)*
/3 -mercaptoethylamine (140 mM)
Microsomal supernatant (20%)
Cofactors:
2.00 ml
0.05 ml
2.00 ml
NADP
Glucose 6-phosphate 
G6P dehydrogenase
(5 mM)
(50 mM) > 
(l unit)
1.00 ml
5.05 ml
* [4-^c] Cholesterol was prepared according to the method of Karaboyas 
and Koritz (19^5). Benzene was evaporated from vials containing 5/jCi 
[4- c]cholesterol (approximately 8.7 nmol cholesterol) after which 
6 ml of 12 mg/ml Tween 80 in acetone was added. The acetone was then 
evaporated off and the residue was redissolved in 20 ml of 0.1 M potassium 
phosphate buffer, pH 7.4. This amount would be sufficient for 10 
incubates.
An incubation period of 1 hour was allowed in a shaking water 
bath (60 cycles/min) at 37°C. A control incubate containing boiled 
microsomal supernatant was also prepared and run through the assay 
procedure.
The reaction was stopped by the addition of 10 ml methanol, 
and neutral lipid was extracted employing the method of Hattersley (1976)
as in Fig. 4.1.
Incubation mixture 
after 1 h reaction
Supernatant
+ 10 ml methanol 
10 min extraction
10 min centrifugation at 2,000 rpm
Pellet
mix for 10 
min; 5 min 
centrifugation 
at 2,000 rpm 
and upper 
layer discarded
supernatant
+ 10 ml chloroform 
10 min extraction 
10 min centrifugation 
at 2,000 rpm.
Chloroform Extract
V
Pellet
+ 5  ml water;
5 min mixing; 
15 min
centrifugation 
at 2,000 rpm; 
upper layer 
discarded
supernatant
Y
+ 5ml hot ethyl acetate 
10 min extraction 
10 min centrifugation 
at 2,000 rpm
Lipid Extract Pellet
discarded
FIGURE 4.1 Assay for cholesterol 7 PO-hydroxylase - extraction procedure
After the series of extractions, the chloroform extract was 
reduced to dryness by means of a rotary vacuum evaporator and the residue 
redissolved in 250/j1 chloroform. A thin-layer chromatography plate 
(silica gel, G-1500) was spotted with 20 >ul of the extract and run in 
toluene-ethyl acetate (7:13 V v)• The radioactive bands on the plate were 
localised by a BerthoId thin-layer radioactive scanner (Fig. -4.2a).
Relevant regions of the plate wore scraped for liquid scintillation 
counting using cab-o-sil scintillant (cab-o-sil ^  w/v and PPO 0.55%
W/v in toluene). Each vial contained 5 ml scintillant and was counted 
for 10 minutes in an UltroBeta liquid scintillation counter.
Spectral Binding Studies
These were based on the method of Schenkman et al. (1967).
Washed microsomal suspensions, which were adjusted to a protein 
concentration of 2 mg/ml for microsomes from untreated rats and 1-2 
mg/ml for microsomes from phenobarbitone- or DDT- induced rats, were 
employed for these studies. All dilutions were made with 0.1M Tris- 
HC1 buffer, pH 7*4. Unless otherwise stated, binding studies were 
carried out at ambient temperature.
Into each of the two matched cuvettes, 3 ml of microsomal 
suspension was added and a baseline was then obtained between 350 nm 
and 500 nm in a Pye-Unicam SP-1800 dual spectrophotometer (sensitivity 
0,2A full-scale deflection). The substrate, dissolved in dimethylformamide 
(DMF), was added to the test cuvette by means of a microsyringe and 
immediately mixed. An equivalent amount of the solvent was introduced 
into the reference cell. A difference spectrum was then scanned and
recorded on .chart paper. The maximal volume of DMF in either cuvette 
-was 10/i 1 (1 mM).
The magnitude of the spectral change (AA^^) was calculated ■
by taking the sum of the peak and trough with reference to the baseline.
For kinetic studies, measurement of AA were made over a range ofmax
substrate concentrations and a double reciprocal plot of Aa againstmax
substrate concentration constructed. From this, by analogy with
Michaelis-Menten enzyme kinetics, the constants K and AA were derived.- . s max
Isooctane Extraction
The method of Leibman and Estabrook (l9?l) was employed.
Microsomal pellets were resuspended in 0.1M Tris-HGl buffer, 
pH 7.6 to give a protein concentration of approximately 30 mg/ml. An 
equal amount of isooctane (2,2,^-trimethylpentane) was added and the 
mixture stirred for 30 minutes at 4°C. A control was also performed 
replacing the isooctane with an equivalent amount of buffer solution.
The resulting emulsion was centrifuged at 157,000 g for 40 minutes in
civ
a Beckman (Model L5-65) Ultracentrifuge.
Analysis of DDT and metabolites in whole liver and microsomal samples 
Extraction procedure
Suitable volumes of liver homogenate or microsomal suspensions 
(1-2 ml) were extracted for determination of DDT residues according to 
the method of Walker et al. (l969).
Samples were dried in a glass beaker with the gradual addition 
of anhydrous spdium sulphate (acetone washed and dried) until the mixture 
gave a loose crumbly appearance; 25 ml of hexane-acetone (2:1 V/v) was 
added and the contents boiled on a water bath for about 3 minutes. The 
liquid was then decanted into a wide-neck round-bottomed flask that 
contained antibumping granules. The procedure was repeated three times 
before completely evaporating off the bulked liquid over the steam bath.
25 ml of hexane was then added and this again was boiled to dryness.
The residue was taken up again in about 1 ml of hexane.
Column Clean-up
Florisil (5g), which had been activated by storage at 120°C,
was deactivated by shaking with Jfo (v/v) water for ^5 minutes. This
was poured into a glass column (20 cm in length; 1 cm diameter) and
washed with 25 ml of 1% acetone in hexane followed by 25 ml of hexane.
The sample was run onto the top of the column by the use of a 
Pasteur pipette followed by a rinse of hexane (total volume of about 2 ml). 
Elution was by kO ml of hexane.
The presence of DDT, DDD and DDE (Fig. A.2b) was determined in
the eluent by electron capture gas-liquid chromatography (Pye series 10^)
cholesterol
band
7<*- hydroxy- 
cholesterol
Fig. ^.2a Localization of radioactive bands on t.l.c. plate by scanner
origin
0.02 ng
DDE
Fig. 2b 
DDT, DDD and DDE by electron- 
capture gas—liquid chromatography
Detection of
0.02 ng 
DDD
CO
0.02 ng 
DDT
RETENTION TIME (MINUTES)
employing a 1 metre column (internal diameter of 4 mm) containing 4$
OV-1 on Gas Ghrom Q, 8O/IOO mesh with a nitrogen flow of 50 ml/min.
The detector temperature was at 300°G with a column oven temperature : 
of 200°C.
Suitable blank and recovery samples were taken through the 
same procedure during each set of determinations. All solvents employed 
had been redistilled before use.
Enzyme Histochemistry
a) Glucose 6-phosphatase - This is based on the method of Wachstein 
and Meisel (1956) in which released phosphate ions from the substrate 
are precipitated as lead phosphate, which is converted to the deep brown- 
coloured lead sulphide. The method is carried out in unfixed cryostat 
sections.
o
Small pieces of tissue ( 5mm ) from the median lobe of the liver 
were placed on metal microtome chucks and frozen using a solid carbon 
dioxide (cardice) and hexane mixture in a shallow dish. Sections (15//) 
were cut within 48 hours in a Bright cryostat (model FS/FRS) at - 20°G
and transferred directly onto clean glass microscope slides.
The liver sections were then incubated for 30 minutes at 37°C 
in 50 ml of 40mM Tris-maleate buffer pH 6.7 containing glucose 6-phosphate 
(sodium salt)r 1.5 mM and lead nitrate, 4.5 mM. After ihcubation the 
slides were taken through the following series of reagents:
1. Distilled water, 2 changes, 2 minutes each.
2. 1% Ammonium sulphide until no further darkening takes place,
1 to 2 minutes.
3. Distilled water for 2 minutes.
4. 6fo (V/v) Formaldehyde solution to fix sections, 5 minutes.
5. Distilled.water for final wash, 2 minutes.
The sections were then mounted in glycerol jelly.
Glucose 6-phosphatase activity was stained brownish black
as a result.
\ f ■
b) Acid phosphatase - Small thin strips (approximately 3 x 10 mm) of 
liver tissue were fixed with formol calcium* at 4°C for 24 hours. The 
strips were then transferred into gum sucrose* for a further 24 hours.
After fixation, the tissue was frozen on a freezing stage unit and sections 
(8 /S) were cut on an 'Om S' freezing sledge microtome (Reichert) with a 
cutting angle of 75°. The cut sections were collected into ice-cold 
gum sucrose before incubation in a freshly mixed solution of 40 ml acetate 
buffer, lOOmM pH 5; 120 mg lead nitrate; 60 ml distilled water and 100 mg 
cytidine 5'-monophosphoric acid. Incubation was carried out in a 37 °C 
oven for 15 minutes.
After reaction, the sections were washed in distilled water and 
then immersed in freshly prepared 1% ammonium sulphide solution for 2 
minutes. After two further washings with distilled water, sections were 
transferred to glass microscope slides and mounted in glycerol jelly.
* Formol calcium - 4^ (V/v) formaldehyde containing 1% (W/v) calcium
chloride.
Gum sucrose - 1 g (V/v) gum acacia in 30^ (W/v) sucrose.
Histology
Tissue from rat livers was fixed in formalin (10% v/v formaldehyde) 
for at least one week. Liver specimens were then embedded in paraffin 
wax and sections (8 /i) were prepared for staining with haematoxylin 
and eosin (H. & E.).
Electron Microscopy 
% ■ Q
Small liver blocks (1-2 mm ) were obtained from a freshly 
killed animal and placed straight into 1% glutaraldehyde (in 50 mM sodium 
cacodylate, 0.25M sucrose pH 7,^). Fixation was allowed for k hours 
at ^°C before rinsing specimens in the sodium cacodylate/sucrose buffer, 
at which stage they may be stored overnight. A second fixation was 
performed in 1% osmium tetroxide solution for two hours at 4°C. (Stock 
solutions: a. 2% osmium tetroxide; b. 0.5% sucrose, 50mM sodium cacodylate). 
Dehydration was then carried out by taking specimens up a series of ethanol
with 2 changes at 10 minutes each in 25%, 5Vf°t 7 %  and absolute solution.
Tissues were then transferred to propylene oxide for 30 minutes.
The solution was then decanted and replaced by an equal mixture of propylene 
oxide and Epon 812*. This was left for 20 minutes with continuous 
swirling. By means of a coarse Pasteur pipette, specimens were transferred 
to the top of Capsules which had previously been filled with the Epon 
812 mixture. Polymerisation was allowed by placing the capsules in the 
oven at 60°G for 48 hours.
* Epon 812 mixture was freshly prepared by mixing equal proportions of
a) Epon 812 62 ml ; dodecenyl succinic anhydride 100 ml,
b) Epon 812 100 ml ; methyl nadic anhydride 89 ml.
All stages involving transfer of specimens were carried out 
in the fume cupboard with particular caution paid to osmium tetroxide. 
Sectioning and staining of the liver samples were carried out by technical 
staff in the Electron Microscopy Unit, University of Surrey.
RESULTS
Effects on body and liver weights
Growth curves for the three animal groups were essentially similar 
(Fig. k. 3). Although in the later stages of treatment, animals in the
5OO ppm group appeared to. exhibit slightly lower body weights when
compared to the other two groups, the difference was not statistically 
significant. * No signs of abnormal behaviour was observed in any animal.
Liver enlargement was observed in the two test groups within 
ten days of treatment. A dose-dependent increase in liver to body 
weight ratio was obtained throughout the course of the experiment (Fig. 
^.^b). Despite the increase in size, the morphology of the livers in all
the DDT-treated animals up to 32 weeks appeared to be normal.
Effects on microsomal drug-metabolizing enzyme activities .
Results from this section are expressed graphically as % change 
relative to control values (Fig. ^.^b-k) as
1) units per mg microsomal protein
2) units per nmol cytochrome P-^501
The actual values used for calculation of these data may be 
found in the Appendix.
Within 10 days of DDT administration, microsomal protein was 
significantly raised in both test groups accompanied by a marked increase 
in drug-metabolizing enzyme activities and related parameters. Cytochrome 
P-^50 levels were increased to over 200% of control values with a near
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FIGURE 4,4 Effects of DDT on some .drug-metabolising .enzyme parameters
during chronic dietary administration to rats
Results are expressed as % of control values (for number of animals per 
group see 'Methods*).
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parallel rise in Diphenyl 4-hydroxylase and p-nitroanisole O-demethylase. 
NADPH-cytochrome c reductase and aniline hydroxylase were also raised hut 
to a lesser degree and this may be seen when activities are expressed 
in terms of cytochrome P-450 concentration. Biphenyl 2-hydroxylase and 
7-ethoxyresorufin O-deethylase activities were greatly enhanced to levels 
equal or above the extent of cytochrome P-450 increase. Only approximately 
k'J/o enhancement was observed with cytochrome b^ content or cholesterol 7°<“ 
hydroxylase activity at this interval.
 ^ ''d’
Generally, the degree of induction fell slightly at week 4 
in both test groups but no further decrease was observed thereafter. 
Induction of most parameters was sustained up to the termination of the 
experiment.
Cytochrome b^, which was not greatly elevated at day 10, was 
found to be further increased at week 4 and the induction was sustained 
from thereon. In contrast, cholesterol 7*-hydroxylase activity fell to 
near or below control levels at week 4 and remained unaffected or slightly 
decreased. Biphenyl 2-hydroxylase was greatly increased as treatment 
continued, reaching 10 times control values by week 16. Similarly, 7~ 
ethoxyresorufin O-deethylase activity was further raised after day 10.
The extent of induction in the two test groups did not differ 
significantly, although generally, the 500 ppm group exhibited slightly 
greater enhancement than the lower dose group throughout, the study.
Spectral “binding studies 
Hexobarbitone
Hexobarbitone formed a typical type I spectral change (peak
390 nm; trough 422 nm) with both control and DDT-induced microsomes.
The maximal spectral change (AAmax) was greatly increased with the 
insecticide-induced microsomes (Pig. 4.5). This increase was above 
that of the increase in cytochrome P-450 content and was sustained up
to week 32. DDT did not affect the affinity of microsomes for hexo­
barbitone, i.e. control and induced microsomes had similar K (-1.5 inM )s
values even after prolonged treatment (Fig. 4.6).
DDT ■ ' ^
DDT interacted weakly with cytochrome P-450 of control microsomes
to produce a type I spectral change. The spectrum observed was frequently
small and incomplete, e.g. the trough may be absent, rendering the
determination of AA difficult. The values were inconsistent and. . max .
therefore, the % increase over control values for AA was not calculated.* . ' max
With DDT-induced microsomes, the spectral change was significantly 
greater in magnitude than that obtained with control microsomes. However, 
in this case, the type I spectrum (peak 388 nm; trough 418 nm) gradually 
developed with time of incubation (Fig. 4.10). A small and incomplete type 
I spectrum was obtained immediately after the addition of DDT, but with 
repetitive scanning, a typical type I change emerged and progressively increased 
in magnitude with time reaching its maximum 20 minutes after addition of substrate 
(Fig 4.7). Due to this time-dependency, the affinity of induced microsomes
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Fig 4.5 Effect of DDT treatment on binding of hexobarbitone to microsomes
Results are expressed as % increase of AA of test samples as compared
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to control values.
O O units per mg microsomal protein (250 ppm); -© for 500 ppm.
A-— -A units per nmol cytochrome P-450 (250 ppm); A —  A for 500 ppm.
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Fig. 4.6. K_ value for hexobarbitone at various stages of DDT treatment
Results are expressed as values of a single determination.
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Fig. 4.7 Concentration and time dependency of the development 
of Type I spectrum by DDT with DDT-induced microsomes
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Fig.-4.8 Effect of temperature on development of Type I spectrum
by DDT (0.5 mM) with phenobarbitone-induced microsomes-
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for DDT was found to increase slightly with time (Fig. 4.9).
The time-dependency. of DDT binding to cytochrome P-450 was 
further investigated using microsomes from DDT- and phenobarbitone-induced 
rats that were pretreated by short-term intraperitoneal injections. Rats 
were treated with 3 doses of either DDT (l60 mg/kg) or phenobarbitone 
(75 mg/kg) for the experiment (for details see 'Methods*). Basically, 
no differences were observed with the two types of microsomes in terms of ’ 
their affinity towards DDT and the rate of formation of the type I spectrum, 
i.e. the time-dependency is seen in both phenobarbitone-induced and DDT- 
induced microsomes. '
The effect of temperature on the formation of the spectral change 
by microsomes from phenobarbitone-induced rats is as shown in Figs. 4.7 
and 4.8. At lower temperatures, the development of the spectrum was slower 
and the maximal size reached was smaller. A maximal effect was observed 
when a temperature of 35°C - 40°C was employed for the system. When the 
same type of microsomes were treated with iso octane, spectral formation of 
any type by DDT was completely abolished. No spectrum emerged even after 
30 minutes of repetitive scanning when DDT was added.
DDD, DDE, aldrin and dieldrin all produced a type I spectral 
change with phenobarbitone-induced microsomes though with different 
affinities and size of spectrum (Fig. 4.10). Aldrin and dieldrin 
interacted more readily and formed well-defined type I spectra whereas 
DDD and DDE caused the development of smaller spectral changes (Table 4.2). 
The time-dependent increase in spectral size with these compounds was not 
marked as with DDT and the respective maximal change was observed within
5.to 10 minutes. Little or no time-dependent increase in magnitude of 
the spectrum was seen with aldrin and dieldrin.
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FIGURE 4.10 Time-Dependent Development of Type I Spectra of DDT, DDD and
DDE with Microsomes from Phenobarbitone-Pretreated Rats
TABLE 4.2 Magnitude of Spectral Change and Affinity of Various Compounds 
.with Microsomes from Phenobarbitone-Pretreated Rats
COMPOUND (0.5mM) AW x10"2) K :■ ■:V ... S...
DDT • 5.5 ':5: ■ 0.20 mM
DDD 2.8 0,62 mM
DDE 1.70 nM
Aldrin 10.3 6.5 juM
Dieldrin 18.1 4.5 .juM'
Hexobarbitone 6,4 0.16 mM
3-Methylcholanthrene pretreatment was found to greatly decrease 
the of these organochlorine insecticides despite increases in
cytochrome 'P-450' levels. In the case of the DDT compounds, no spectrum 
could be detected using the sensitivity (0 - 0.2) in the SP-1800 spectro­
photometer.
Insecticide residue concentrations
Tot|Ll (DDT + DDD t DDE) insecticide concentrations in the 500 ppm 
animals were approximately twice that of the 250 ppm groups (Fig. 4.11). 
Similar observations were obtained with the total microsomal DDT residue 
concentrations between the two groups. It is worth noting that microsomes 
although comprising only tyfo of liver weight, contain some 35^ of the 
total amount-of insecticide residues in the liver of animals from either 
treated group, i.e. the concentration of residues in microsomes is about 
ten times greater than in the rest of the liver tissue. No evidence of 
progressive accumulation of insecticide levels in the test animals was 
found, and little or no insecticide residues were detected in the livers 
of control animals.
Concentrations of DDE in both liver and microsomal samples were 
much lower than those of DDT and DDD throughout the experiment period 
(Fig. 4.12). DDD levels exceeded DDT levels at week 4 and week 8 but 
fell slightly below that of its parent compound thereafter.
Histological studies
No hepatocellular damage was observed in the treated rats and the 
general architecture of the liver lobules was similar to that Of control 
animals up to 32 weeks. After 32 weeks of treatment, vacuolation due 
to lipid infiltration, as Shown by Red 0 lipid stain, was observed in the
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Concentration of total DDT residues in the liver and liver 
microsomes of DDT-treated animals
Results are means of determinations with, six animals except at week 32 where 
samples from four animals were pooled and a single determination obtained. 
Liver samples from A— A 250 ppm groups and ▲-- ▲ 500 ppm groups;
Microsomal samples from D—— □ 250 ppm groups,and H— —a 500 ppm groups.
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cytoplasm of hepatocytes. This resulted in the migration of cytoplasmic 
materials to the periphery of the cells. However, this effect was also 
observed in livers of control animals hut to a lesser extent. Cell 
enlargement was observed in the centrilobular regions in both groups of 
the treated animals from day 10 onwards. No cell necrosis was observable 
in either group up to 32 weeks of treatment.
Histochemical^and ultrastructural studies
Acid phosphatase activity appeared abundantly in the peri­
canalicular regions of the liver cells in the control rats. No change 
of this distribution was observed at any time of the study in the treated 
animals although the activity appeared less in the centrilobular regions.
Glucose 6-phosphatase was found to be markedly depressed in 
centrilobular regions of the liver lobules with DDT treatment at both 
levels from day 10 onwards.
Electron micrographs were prepared after 32 weeks of DDT 
administration only. Liver samples from control animals at this interval 
were also examined. There was an abundance of smooth endoplasmic reticulum 
in both treated groups but no abnormalities indicative of liver injury, e.g. 
autophagic vacuoles, were observed.
DISCUSSION
The potent stimulatory action of DDT on microsomal drug- 
metabolising enzymes in the rat is well-documented (Durham, 19^7; Sher,
1971; Hayes, 1975). Tbe duration of experiments in the literature for 
most of these studies is relatively short and a sequential study similar 
to the type described here has not been reported. The results presented 
in this project are, however, consistent with previous findings of an 
increase in microsomal protein (Morello, 19&5) accompanied by liver 
enlargement (platt and Cockrill, 1967), hypertrophy of the smooth endo­
plasmic reticulum (Fouts and Rogers, 1965; Ortega, 1966) and great elevation 
of various mixed-function oxidase activities (Azarnoff, 1977> Hart and 
Fouts, 1965). It would appear that a dietary level of 250 ppm is sufficient 
to elicit maximal stimulation of the mixed-function oxidases since there 
was little difference in the levels of induced enzyme activity between 
the two dose groups. The marked difference in the total insecticide 
levels of the two treated groups, both in the liver and microsomes, indicates 
that high DDT. levels present in the 500 ppm group did not affect enzyme 
induction to any great extent such as might give rise to hypertrophic hypo- 
active endoplasmic reticulum. In some agreement with previous findings by 
Hoffman et al. (1970) in a two week study, levels of enzyme induction 
were maintained up to a dietary concentration of 750 ppm. Above this 
dose level, however, decreases in p-nitroanisole O-demethylase activity 
and liver weights, as well as signs of neurotoxicity, were observed.
An important feature in these results is that the enzyme in­
duction in both the 250 ppm and 500 ppm groups was sustained throughout the
experimental period. This is in contrast to the situation reported for 
dieldrin, where, a phenomenom named hypertrophic hypoactive smooth enodplasmic 
reticulum (HHER) was described (Hutterer et al_., 1968), and for a number 
of other hepatotoxins and carcinogens. It is noteworthy that in HHER, a 
high level of cytochrome P-450 is present but a loss of microsomal enzyme 
activities can be observed, whereas enzyme induction in the DDT-treated 
animals is characterised by a significant increase in cytochrome P-^50 
paralleled b^ r a similar rise in drug-metabolising enzyme activities. The 
response obtained with DDT, therefore, appears to resemble the persistent 
induction of drug-metabolising enzymes and related parameters when pheno- 
barbitone or butylated hydroxytoluene was chronically administered to rats 
(Wilson and Fouts, 1966; Crampton et al., 1977a). The latter two compounds 
are considered to cause liver enlargement as a physiological adaptive 
response rather than an indication of toxicity since no pathological changes 
could be detected, and the response was reversible on cessation of treatment. 
This response has been viewed as a hyperfunctional response to ingestion 
of a metabolisable xenobiotic with the effect of accelerating the rate of 
elimination of the compound and preventing its accumulation in body tissues 
(Conney et al., I960; Golberg, I966; Gilbert and Golberg, 1965). This 
interpretation is strengthened by the absence of histological or ultra- 
structural evidence of liver injury. Liver cell necrosis was not found, 
and centrilobular cell enlargement and cytoplasmic vacuolation, due to 
the infiltration of lipids, are as indicated in previous reports with 
DDT or dieldrin (Hurkat, 1977; Laug et al., 1950; Ortega, 1966; Kimbrough 
et al., I97I).
HiStochemical studies revealed a centrilobular depression of 
glucose 6-phosphatase in the treated animals, which for certain compounds
is indicative of liver damage (Pitot, I96O; Feuer et al., 1965? Grasso 
et al., 197^). This effect is, however, not considered to be a toxic 
response when observed with increases in drug-metabolising enzyme activities 
as induced by compounds such as phenobarbitone or butylated hydroxytoluene 
(Crampton et al., 1977a; Grasso et al., 197^)• Under these conditions, 
glucose metabolism via the hexose monophosphate shunt may be enhanced to 
increase the intracellular availability of the reduced NADP required by 
the mixed-function oxidase system. A concomitant decrease in glucose 6- 
phosphatase activity may therefore be expected. That the centrilobular 
depression of glucose 6-phosphatase is not indicative of cell injury is 
borne out by the absence of lysosomal changes in the centrilobular cells.
However, the biochemical interpretation of the changes in glucose 
6-phosphatase activity is complicated by the known action of DDT in 
stimulating glucose 6-phosphatase both in vitro and in vivo (Kacew and 
Singhal, 1972,1973, 1973a).
Early involvement of acid phosphatase rich lysosomes has been
observed in liver damage (Slater, 1966; Matsumoto and Suga, 1978). A
change in the normal pericanulicular distribution of acid phosphatase
activity as observed histochemically would therefore provide an index
for possible hepatotoxicity and Grasso et al., (197^) have provided evidence
to support the view. The acid phosphatase distribution pattern of
lysosomes was maintained in livers of the DDT-treated animals, and no
autophagic vacuoles (-Grasso et al., 197^) were observed in electron
microscopic preparations. These results therefore provide no evidence
of hepatocellular damage under the conditions and duration of this study. 
Although it was shown that DDT can cause the labilisation of lysosomal
membranes in vitro (Rogers et al., 197&), this is apparently not true under
conditions as studied here.
Another parameter which may provide information as to the possible 
damaging effects of a compound is. the presence of cytochrome P-448, the haemo- 
protein that is associated with carcinogenic compounds. Biphenyl 2- 
hydroxylase and 7-ethoxyresorufin O-deethylase are such enzymes that are 
solely cytochrome P-4^8 dependent (Burke and Mayer, 1975). Biphenyl 2- 
hydroxylase activity was shown to be greatly elevated during the prolonged 
treatment with DDT. However, the expression of results is somewhat 
misleading for, in agreement with previous findings (Basu et al., 1970; 
McPherson et al., 197^), the basal level of this enzyme greatly decreased 
with age in the control rats. The results calculated as percentage of 
control values therefore show a progressive increase in the treated 
animals although the absolute rate of 2-hydroxylation was unaltered and 
even decreased from day 10 (see Appendix). The relatively constant levels 
obtained from the treated rats up to 32 weeks of both "biphenyl 2-hydroxylase 
and 7-ethoxyresorufin O-deethylase probably indicates the attainment of a 
steady state. Since the absolute enzyme activities did not increase 
progressively with treatment period, as is known to occur with a number of 
carcinogens (Gray, 1975)» the induced levels of biphenyl 2-hydroxylase, 
and by implication of cytochrome P-^48, need not be indicative of tissue 
injury. The high increase in biphenyl 2-hydroxylase activity is not 
surprising since a two to three fold increase was observed after a single 
intraperitoneal injection of the compound (see Chapter 2).
The fall of basal activity in control rats of these cytochrome 
P-148 enzymes points to either a lower hepatic content of this cytochrome 
in adult animals, at least in the Wistar Albino strain, or that a change occurs 
in the microenvironment of membrane with age thus preventing Its action 
in the untreated rat.
The induction of drug-metabolising enzyme system would likely 
increase the metabolism of endogenous substrates and hence alter the 
physiological state of the animal. DDT is known to increase the rate of 
hydroxylation of various steroids (Conney, 1967; Kupfer and Bulger, 197&; 
Balazs and Kupfer, 1966) whilst causing an increase in drug metabolism.
The enzyme investigated in this study was cholesterol 7 ^-hydroxylase, which 
is a mixed-function oxidase (Boyd et al., I969; Mltropoulos and 
Balasubramanian, 1972; Wada et al., 1968; Bjorkhem et al., 1975) and 
controls the overall rate of bile acid biosynthesis from cholesterol 
(Danielsson et al., 1967; Shefer etal., 1970)• Since it is a cytochrome 
P-450 dependent enzyme, administration of phenobarbitone to animals would 
be expected to elevate cholesterol 7 0(-hydroxylase activity. But results 
from these experiments have been contradictory in that the activity was 
unchanged (Einarsson and Johansson, I968), slightly depressed (Balasubra­
manian and Mitropoulos, 1975) or enhanced (Mosbach, 1969). These 
discrepancies may be partly explained by the multiplicity of cytochrome 
P-450 in which the specific form required for cholesterol 7K“bydroxylase 
in some strains of rats is not elevated by phenobarbitone. However, a 
different response was obtained with the same strain of rat (Sprague- 
Dawley) in two different laboratories (Wada et al., 1968; Einarsson and 
Johansson, 1968). The depression of activity by 3-^othylcholanthrene is 
also known (Mellon et al., 1978). It would be fruitful to compare 
particular forms of cytochrome P-450 induced by cholestyramine, which 
greatly elevates cholesterol 70(-hydroxylase activity, and those induced by 
phenobarbitone or 3-raethylcholanthrene.
DDT failed to stimulate cholesterol 7 O'-hydroxylaSe despite the 
high induced levels of cytochrome P-450.. Chlorinated hydrocarbons have
been shown to cause selective increase of high density lipoprotein (HDL) 
cholesterol in rats (ishikawa et al., 1978) and men (Carlson and Kolmodin- 
Hedmen, 1972). This observation at first appears to provide an explanation 
of the effect obtained with DDT if HDL-cholesterol is not utilised as a 
substrate for bile acid biosynthesis. However, it was shown recently that 
in man, HDL-cholesterol is the preferred precursor for biliary cholesterol 
(Halloran et al., 1978). Perhaps the suggestion by Myant and Mitropoulos 
(1977) that an additional controlling factor which for example, facilitates 
the availability of cholesterol to the active site of the microsomal enzyme 
system, would prove valid in explaining the results observed.
Other observations of interest included the time-related 
development of type I spectrum caused by DDT with microsomes from 
phenobarbitone- or DDT-induced rats. This may reflect the availability 
of the compound to the active site of cytochrome P-450, but why it occurs 
with a highly lipophilic compound like DDT is not understood. The 
observed effect is not due to steric hindrance since other lipophilic 
compounds such as piperonyl butoxide, which has a heavily substituted side- 
chain, interact readily with cytochrome P-450 (Matthews et al., 1970).
The phenomenom suggests DDT to be an atypical substrate since the time- 
dependent spectral change should have been abolished if animals are 
repeatedly administered with DDT for an equilibrium is presumably 
established in the liver after such treatment.
The binding of DDT to cytochrome P-450 was enhanced with an increase 
of temperature, presumably by causing the membrane to assume a more fluid 
environment (Stier, 1976) thus facilitating the interaction between DDT
and the cytochrome. The importance of the presence of membrane lipid was
also demonstrated when the spectral change was completely abolished by
isooctane extraction. This is in agreement with previous findings that
a loss of type I binding capacity by microsomal preparations was attended
upon extraction with isooctane (Leibman and Estabrook, 1971). Similar
effects can be observed after enzymatic hydrolysis of microsomal phophatides
(Shoeman et al., 1969; Chaplin and Mannering, 1969). These observations
are in suppoTt of recent findings that type I substrates do not bind
directly to the haem iron of cytochrome P-450, but interact with
the apoprotein moiety of the cytochrome (Yoshida and Kumaoka, 1975)*
The pretreatment of rats with 3-wet-hylcholanthrene, which induces cytochrome
P-448, further points to the finding that DDT behaves like a type I
substrate whose AA is significantly decreased employing such microsomesmax
(Schenkman et al., I967).
Cytochrome b^ is not normally elevated with DDT pretreatment to 
rats (Platt and Cockrill, 1967). This is observed at "the first interval 
where at day 10, the cytochrome is only slightly though significantly 
increased. The increase, becoming more marked with longer treatment, is 
in agreement with the observation that cytochrome b^ can be further 
elevated with phenobarbitone after repeated administration (Conney and 
Klutch, I962; Kuriyama et al., 1969). The exact role of this haemoprotein 
is uncertain, but for certain substrates, cytochrome P-450 can accept 
reducing equivalents from cytochrome b^ (imai and Sato, 1977; Hildebrandt 
and Estabrook, 1971; Lu et al., 1974) and its participation in desaturation 
of fatty acid is generally recognised (Schenkman et al., 1976; Johansson 
and Schenkman, 1977). The induction of cytochrome b^ may possibly 
contribute to the enhancement of microsomal drug oxidation observed in 
this study.
GENERAL DISCUSSION
GENERAL DISCUSSION
The behaviour of organochlorine insecticides in short-term mutagenicity 
test systems
The function of microsomal mixed-function oxidases is generally 
considered to be the detoxification of xenobiotics, but many compounds, for 
example polycyclic hydrocarbons, are also transformed by -the enzyme system 
into their reactive metabolites (Grover and Sims, 1968; Gelboin, 1969;
Oesch et al., 1972). These metabolites are electrophilic reagents which 
can attack nucleophilic centres of DNA and other biological macromolecules 
(Heidelberger, 1973) . Such reactions are believed to form the basis of 
the mutagenic activity of these reactive metabolites.
Many agents known to be carcinogenic in animals are also mutagenic 
and there is considerable evidence suggesting that mutagenesis and 
carcinogenesis are related processes (Miller and Miller, 1975; Ames et 
al., 1975). In view of this correlation, systems capable of demonstrating 
mutagenic activity have been developed as a rapid method of identifying 
potential chemical carcinogens. However, there are some carcinogenic 
compounds which do not show mutagenic activity, and this may be due to the 
failure of these compounds to be metabolised to reactive intermediates in 
the test systems employed, or to some alternative mechanism of 
carcinogenesis (epigenetic mechanisms).
DDT is a stable compound and metabolic activation may be essential 
before it can express any mutagenic action in systems, such as the Ames 
test. Indeed, the negative result., obtained in the Ames test (Marshall
et al., I976) has been attributed to the inadequacy of the microsomal 
fraction present in the test system to reproduce in vivo mammalian metabolism 
(Rickard et al., 1978) . It was found that only a small percentage of DDT 
(about 20%) was metabolised in this system during a 48 hour incubation. 
Dieldrin has also been shown to be negative in the Ames test (McCann and 
Ames, 1976). Other in vitro studies on the metabolism of dieldrin by liver 
microsomal preparation from rats show that a high percentage of dieldrin 
remains unconverted to metabolites (Oberholser et al., 1977* Matthews and 
Matsumura, 1969).
Since both DDT and dieldrin have been shown to be carcinogenic 
in some animal species in long-term carcinogenicity studies (Rossi et al., 
1977; Fitzhugh et al., 1964; Innes et al., I969) whilst giving negative 
results in the Ames test, some explanation is required for the atypical action 
of these compounds. The inability of the microsomal preparations used in 
the Ames test to actively convert these compounds to their respective 
reactive metabolites appears to be one possible reason for negative responses 
obtained in this test system. An alternate explanation, which will be 
discussed in a later section, may be that these agents exert their action 
at sites other than DNA.
There is no direct evidence from any study showing the interaction 
of DDT or its metabolites with DNA. However, a very small amount of an 
unidentified product of dieldrin has been shown to become tightly bound to 
liver DNA in both the mouse and rat (Dean et al., 1975) • The extent of 
binding was related to microsomal metabolism of the species involved.
Thus, the rat, having a faster conversion rate of dieldrin than the mouse, 
had a higher extent of binding. Since rats have been reported to be 
relatively insensitive to tumour development with dieldrin, it is unlikely
that this interaction with DNA results in chemical mutagenesis (Wright 
et al., 1977). However, there is evidence that dieldrin may cause DNA 
damage as it induces unscheduled DNA synthesis in the human cultured cell 
system even without metabolism by microsomal supernatant (S9) (Ahmed et 
al., 1977). The ability of a compound to induce unscheduled DNA synthesis 
is a meas\ire of excision repair in the cell cultures. In man, a relation­
ship exists between the lack of excision repair and tumour occurence in the 
disease, xerQderma pigmentosum (Cleaver, 1968), and this has prompted the 
investigation of DNA repair as a screening procedure for detecting potential 
mutagens (Liebman, 1975). -DDT was found to be inactive in this test, but 
again whether the insecticide was metabolised by the S9 fraction in the 
system is unknown.
Another problem with the use of rat liver microsomal preparations 
for metabolic activation of the suspected carcinogen in many of these short­
term tests, is the validity of this metabolism compared with that which 
occurs in the intact animal. Furthermore, the metabolic profile in the 
rat is likely to differ from that in man and other mammalian species. The 
balance between activating and deactivating metabolism in vitro is also an 
important factor in short-term tests. For example, the mutagenic effect 
of benzpyrene can be masked when guinea pig S9 fraction is used in the 
Ames test instead of pure microsomal fraction (Ashby and Styles, 1978). 
Therefore, in the supernatant of S9 fraction are enzymes which are capable 
of inactivating the epoxide intermediates of benzpyrene.
The behaviour of organbchlorine insecticides in short-term test systems 
which do not measure mutagenicity
Some weak carcinogens may exert their action on sites other than
DNA, and this would explain why compounds such as chloroform (Uehleke et 
al,, 1977) and other halogenated hydrocarbons (McCann and Ames, 1976;
Marshall et ad.., 1976) gave negative response in the Ames test. These 
compounds are classified as epigenetic carcinogens (Ashby et al., 1978).
The investigation of other effects caused by carcinogens may lead to a 
better understanding of the action of some potentially hazardous chemicals 
which are not DNA reactive. In addition, test systems may be devised to 
detect such changes.
The finding that carcinogens caused degranulation of the rough 
endoplasmic reticulum (Gustafsson and Afzelius, 1963) offers a possible 
means of carcinogenicity testing for the above mentioned compounds.
This effect can be observed by electron microscopy (Posneret al.,1961; 
Orrenius, 1965)> and the in vivo phenomenom was demonstrated in vitro by 
the measurement of disulphide rearrangease, which increases in activity 
with the degree of degranulation (Williams and Rabin, 1971# Williams and 
Parry, 1975; Dani et al., 1976). The carcinogen aflatoxin was found 
to interact at a site on the membrane for the manifestation of the effect. 
Degranulation by aflatoxin can be antagonised by certain steroid hormones 
that normally promote the binding of ribosomes to smooth membranes 
(Sunshine et al., 1971; Blyth et al., 1971). The pattern of protein 
synthesis would be affected as a result of extensive degranulation. For 
instance, glycoprotein synthesis which normally occurs only in endoplasmic 
reticular bound ribosomes (Halliran et al., 1968) would become inhibited, 
and at the same time an increase in intracellular protein production may 
occur resulting in major physiological changes (Parke, 1979).
The in vitro 1degranulation' technique has been developed and a 
good correlation between various in vivo carcinogenicity tests and the degree
of degranulation obtained (Wright et al., 1977). In agreement with long­
term chronic studies, dieldrin and DDT for example, were found to cause 
significant degranulation in the mouse but not in the rat. Furthermore, 
the use of human liver preparation for this test, and for other short-term 
systems such as the Ames test, could provide more meaningful information as 
to the action of a variety of suspect carcinogens in man.
It is of interest to note that relative to the smooth endoplasmic
• f
reticulum, there is a greater amount of rough membrane in the mouse liver 
(Gram et al., 1971). It is suggested that the extent of degranulation in 
this species would be greater than in other animals, such as the rat, guinea
pig or monkey, for a given compound (Parke, 1979). Therefore, the
disruption of normal physiological activities by a carcinogen in the mouse, 
as a result of degranulation of the rough endoplasmic reticulum would be 
greater than the effect exerted on other mammalian species.
The biphenyl system offers an alternate possibility as a screening 
test for epigenetic carcinogens since the action of carcinogens on this 
system is also at the endoplasmic reticulum. Degranulation of the rough 
endoplasmic reticulum and the stimulation of biphenyl 2-hydroxylase activity 
both provoked by carcinogens, may be related processes (Parke, 1976). 
However, a direct relationship does not seem to exist since the stimulation 
of biphenyl 2-hydroxylase required a much shorter period to attain maximal 
effect (McPherson et al., 1976), Also, agents such as EDTA, which cause 
extensive degranulation (Rabin et al., 1971» Lin and Farber, 1977)> failed 
to have an effect on biphenyl 2-hydroxylase (McPherson est al., 1974), 
although the cytotoxic effect of EDTA is likely to be so severe as to. cause 
complete disruption of the endoplasmic reticulum and its constituent enzymes
Fluorescent metabolites of carcinogens, which interfered with 
the biphenyl assay cast doubts as to the validity of the in vitro test as 
employed by McPherson etal.(197^)» although compounds which do not form 
fluorescent products may still be applicable to this system. Further 
experiments are necessary to separate individual metabolites with methods 
such as high-pressure liquid chromatography to reevaluate previous findings.
If by such means, carcinogens are still found to produce a significant 
stimulation of biphenyl 2-hydroxylase in vitro the system would provide a 
simple and inexpensive means of carcinogenicity testing since no other 
microsomal enzyme has been found to exhibit such a specific effect provoked 
by carcinogens. However, the in vitro system does suffer from competition 
between the test compound and the biphenyl substrate for a common metabolic 
system resulting in an effect that may not solely be due to the test 
chemical.
The monitoring of biphenyl 2-hydroxylase activity after administration 
of the test compound to the animal can also provide useful information as to 
th:, action of the compound on the biphenyl system and hence its carcinogenic 
potential. Also, the problem with the interference of fluorescent 
metabolites in the in vitro test would be reduced or eliminated in the 
in vivo situation. With regard to the in vivo test, however, other 
cytochrome P-448 dependent enzymes, such as 7-ethoxyresorufin Q-deethylase 
activity (Burke and Mayeh, 197^) r/are just as convenient to measure as 
biphenyl 2-hydroxylase. Moreover, some compounds such as safrole may 
form a tight complex with cytochrome P-^50 resulting in a decrease in 
biphenyl 4-hydroxylase activity. Other compounds may similarly affect 
biphenyl metabolism in the animal to produce doubtful results.
The organochlorine insecticides, when applied to the in vitro 
biphenyl system, gave slight but statistically significant enhancement of 
biphenyl 2-hydroxylase activity with mammalian microsomal preparations.
Since alternative methods, as mentioned, have to be employed for further 
validation of the in vitro test, definite conclusions as to the meaning 
of these results cannot be drawn. The weak stimulatory effects could be 
viewed as reflecting the weak carcinogenicity of these compounds in vivo. 
However, there was a lack of differentiation in the extent of enhancement 
of the enzyme between mammalian species which differ markedly in their 
response to organochlorine insecticides in vivo. This, together with the 
poor reproducibility of the results undermines confidence in the predictive 
value of the in vitro system. The in vivo experiments performed by single 
administration of various chlorinated compounds to rats show that biphenyl 
2-hydroxylation is generally elevated, but no clear distinction was obtained 
between o(-benzene hexachloride, which has been shown to be carcinogenic in 
rats (Nagasaki et al., 1972) and the non-carcinogenic, ft-benzene hexachloride, 
The short-term biphenyl test appears, therefore, not to be an ideal system 
for the application of these 'suspect' carcinogens to assess their 
carcinogenic potential.
A possible explanation for the carcinogenic actiqn of DDT
The hepatocarcinogen, safrole, inhibits mixed-function oxidases 
as a result of an intermediate product in its metabolism binding strongly 
to the haem iron of cytochrome P-^50 (Franklin, 1977)• Ullrich (1977) 
has suggested that this intermediate is a carbonium ion. An initial
phase of enzyme induction hy safrole (Crampton et al ., 1977) can he observed 
before the formation of the metabolic-intermediate complex that inhibits 
cytochrome P-^50 associated enzyme activities. Complex formation and the 
resulting inhibition of drug metabolism have been implicated in the 
development of pathological changes in the livers of safrole-treated animals 
(Parke and Gray, 1978). There is evidence that a carbene complex is also 
formed as a result of the Interaction of cytochrome P-^50 with poly- 
halogenated compounds such as chloroform and carbon tetrachloride (Wolf
et ui. , I977).
Results obtained from the in vitro biphenyl test have shown that 
in mammalian microsomal preparations, DDT and DDD, but not DDE, caused the 
enhancement of biphenyl 2-hydroxylase activity. This has led to a proposal 
that the metabolism of DDT involves the formation of a carbonium ion that 
forms a ligand with cytochrome P-^50 (or P-W3): the resulting carbene may 
act as a proximate carcinogen to possibly degranulate the rough endoplasmic 
reticulum (Tong et _al., 1977)• DDE, because of its stable double bond, 
cannot form a carbonium ion and is therefore inactive in the test (see 
Fig. 5.1). Degranulation has been suggested to reveal biphenyl 2-hydroxylase 
activity since in the resulting smooth membrane a cytochrome with the 
spectral characteristic of P-448 is found (Parke, 197&)• In vitro 
stimulation of cytochrome P-^ 4-8 associated enzyme activity may thus be 
possible since de novo protein synthesis is not required for the 
manifestation of such activities (Kahl et al., 1977). However, this 
cytochrome 'P-i|48’ appears to be dissimilar to the cytochrome P-448 as 
induced by carcinogens such as ^ -rcethylcholanthrene (Mailman et al., 1975).
The possibility that DDT may form a ciarbene complex with cytochrome
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P-450 appears to be an attractive hypothesis to explain the carcinogenic 
action of the compound since it is apparently inactive in short-term tests 
that measure interaction with DNA. Mansuy et al. (1978) demonstrated 
that a carbene complex is formed as a result of the reaction of DDT with 
iron porphyrins, in the presence of an excess of reducing agents. The 
interaction of DDT with cytochrome P-450 in vitro under reductive conditions 
has also been briefly examined during the spectral studies in the present 
project. DDT interacted with reduced cytochrome P-450 with the appearance 
of a very small peak at about 456 nm. This peak appears to resemble .the 
spectral characteristics of carbene formation produced by the polyhalogenated 
compounds (Wolf et al., 1977) under similar experimental conditions.
These results therefore point toward the possibility of such a complex 
formation of DDT with cytochrome P-450.
Pretreatment with chlorophenol pesticides, such as pentachlorophenol, 
changes the mode of microsomal metabolism of N ,N-dimethylaniline from C- 
oxygenation to N-oxygenation. N-oxygenation is dependent on molecular 
oxygen, NADPH and a flavin protein, whereas C-oxygenation further requires 
cytochrome P-450 (Arrhenius et al., 1977). This inhibitory effect on C- 
oxygenation may be due to a specific interaction of the compound with 
cytochrome P-450 since the increase in N-oxygenation is interpreted as a 
diminished competition for oxygen from cytochrome P-450. Similarly, 
halogenated antibacterial agents, such as hexachlorophene, have been 
found to inhibit cytochrome P-450 associated reactions (Condie and Buhler, 
1978). This might be a common phenomenon of chlorinated molecules, and 
other compounds, which form ligand complexes with cytochrome P-450 and 
consequently inhibit its hydroxylating activity. Since NADPH-cytochrome
c reductase activity is unaffected by these compounds (Condie and Buhler,
1978),. the decoupling of the normal electron transfer to cytochrome P-450 
from the reductase may possibly lead to increased lipid peroxidation and 
damage to the endoplasmic reticulum (Suarez et al., 1972).
Relation of the inductive effect of organo chlorine insecticides to the 
activation/detoxication of xenobiotics
Organo chlorine insecticides are potent drug-metabolising enzyme 
inducers. The inductive effect caused by these compounds is observed in 
laboratory animals as well as in man (Azamoff, 1977). High drug- 
metabolising enzyme activities, as a result of enzyme induction, may be 
beneficial if the foreign compound is rendered inactive, "but harmful when 
toxic metabolites are produced. The inductive effect exerted by many 
organo chlorine insecticides, even at relatively low dose levels, can 
therefore exert an important influence on their own metabolism as well as 
on chemicals, such as food additives, that are generally present in the 
human diet. Contaminants and food additives in the human diet are generally 
present in amounts below the threshold levels at which the individual 
compounds may cause microsomal enzyme induction. However, in contrast 
to the non-additive effects on microsomal enzyme induction by the 
administration of maximal doses of two inducers of the same type in rats 
(Hart and Fouts, 1965; Mullen et al., 1966; Parkki et al., 1977)> low 
levels of DDT and phenobarbitone have been found to exert an additive 
action (McClean and Driver, 1977). This suggests that the concept of 
threshold dose for induction may be misleading where there is exposure to 
several inducers, each at sub-threshold levels.
In addition to the important role of the mixed-function oxidases 
for the metabolism of xenobiotics, there are a number of other enzymes in
the cell, e.g. epoxide hydrase and glutathione-S^-transferase, which exert 
a significant influence on the fate of foreign compounds in the animal 
body. Epoxide hydrase (Oesch et al., 1972), which transforms epoxides 
into dihydrodiols, is located in the endoplasmic reticulum whilst 
glutathione-S-transferase (Hayakawa et al., 1975)> which metabolises diols 
or phenols into soluble conjugate:* is found in the cytoplasm of the cell. 
These enzymes therefore convert electrophilic intermediates into nontoxic
substances that do not react with biological macromolecules. Thus, if
■? ■ ; ..
epoxide hydrase activity is greater than the rate of conversion of a 
carcinogen to its reactive intermediate by the mixed-function oxidases, 
toxic effects may not be produced. For example, 3-raethylcholanthrene 
inhibits bromobenzene-induced liver necrosis apparently by accelerating 
deactivation of the reactive bromobenzene epoxide as a result of induction 
of epoxide hydrase (Zampaglione et al., 1973). In some cases, however, 
dihydrodiols can be recycled through the mixed-function oxidase system and 
transformed into dihydrodiol epoxides which are reactive towards cellular 
components such as DNA (Sims et al., 1975). Any evaluation of the safety of 
compounds such as DDT irust therefore take into account the implications 
of microsomal enzyme induction.
Relation of the inductive effect of organochlorine insecticides to the 
toxicity/carcinogenicity of DDT and dieldrin
Dieldrin is an epoxide and its effect on epoxide hydrase in the 
rat has been investigated (Bellward et al., 1975) . This enzyme was found 
to be greatly elevated (115^ above control values) by dieldrin after animals
were exposed to dietary levels of 25 ppm for one week. Cytochrome P- 
450 levels were also increased hut to a lesser extent (39% over control).
On the assumption that dieldrin is a substrate of epoxide hydrase, it 
appears that dieldrin enhances its own metabolism to a nontoxic compound.
It is generally known that dieldrin is metabolised in the 
animal body by the microsomal mixed-function oxidase system (Nakatsugawa 
and Morelli, 1976). A species difference in the extent of dieldrin 
metabolism htus been found in the mouse and the rat (Baldwin et al., 1974; 
Hutson, 1976). Due to the slower metabolism of dieldrin in the mouse, 
dieldrin would be more likely to accumulate in this species and may explain 
why this species exhibited tumour formation. Mouse is also known to have 
a lower level of epoxide hydrase than the rat (Oesch et al., 1972) and 
detoxication of dieldrin may be less efficient in mouse. This explanation 
of the accumulation of dieldrin in mice may not be valid if one considers 
the higher dieldrin residues concentrated in livers of dogs (Hutson, 1976), 
monkeys and man (Wright et al,, 1978) after treatment with the insecticide 
at lower dose levels than used in rodent experiments. An elevation in 
drug-metabolising enzymes is considered to be the earliest detectable 
change caused by dieldrin (Wright et al., 1972), and the thresohold for 
such an effect in squirrel monkeys was higher than in rodents pointing to 
a lower sensitivity of the primates towards the compound. Therefore, the 
relatively high dieldrin residue present in monkey livers appeared to be 
inconsequential since no liver toxicity or tumours were detected after a 
6 year feeding study at 5 ppm (Wright et al., 1978).
In contrast, monkeys (juchau et al,, 1966) appeared to be more 
responsive to DDT than rats (Hart and Fouts, 1965) with respect to maximal
stimulation of microsomal enzyme whereas the mouse is relatively less 
responsive (Cram and Fouts, 1965) except after repeated administration 
(Abernathy et al., 1971). The shorter duration of induction observed in 
mice after cessation of DDT treatment (Abernathy et al., 1971) may reflect 
a more rapid metabolism of the compound. Similarly, mouse metabolises 
chloroform at a faster rate than the rat or squirrel monkey (Brown et al.,
1974), and this may lead to greater hepatocellular damage in the mouse 
(Parke, 1979}. The pattern of metabolism of a foreign compound by 
microsomal mixed-function oxidases in a particular species and their 
toxicological responses are highly important in relation to the manifestation 
of cellular damage that may lead to carcinogenesis. These differences 
between rodents and men further empasize the caution required in interpreting 
data from carcinogenicity experiments using mice or rats as a model for 
human or even other animal species.
With the exception of two studies which indicated an increase 
in tumour incidence after rats have been kept on high dietary concentrations 
of DDT or phenobarbitone (Rossi et al., 1977; Fitzhugh and Nelson, 1947)> 
other studies have shown that these compounds are only carcinogenic in 
the mouse (Thorpe and Walker, 1973; Peraino: et al., 1973; Ponomarkov et 
al., 1975) :• but not in the rat (Peraino et al., 1975; Wright et al., 1972;
Schmahl and Habs, 1976). These compounds are also potent microsomal 
enzyme inducers in the mouse and it appears that a relationship exists 
between these two responses. Thus, DDF, which greatly increased drug- 
metabolising enzyme activities in the mouse (Pasha, 1978) caused a great 
increase in the incidence of liver tumours in this species (Tomatis et al.,1974) 
whilst DDD is relatively inactive both as a tumorigenic agent and an enzyme
inducer. The unsuitablity of the mouse as a model for carcinogenicity 
testing has been discussed (Roe and Grant, 19?0; Grasso and Crampton, 
1972; Grasso, 1976). In addition, some workers have disputed as to 
whether liver lesions seen in mouse livers after phenobarbitone or 
organochlorine insecticide treatment were true carcinomas (Thorpe and 
Walker, 1973; Butler and Jones, 1978).
In vivo studies on the possible hepatotoxicity of DDT to animals and its 
implication to man
Against a background of unclear results from short-term test 
studies and in vivo carcinogenicity studies, a long-term sequential 
biochemical and morphological study was conducted with DDT in the present 
project. Rats were used as an experimental model in this study since 
tumours were found to ultimately develop in this species during a life­
span feeding study at a high dietary dose of 500 ppm (Rossi et al., 1977). 
If liver tumours are to develop in the rat, biochemical changes must 
precede their appearance. This has been observed with similar long-term 
studies on the hepatotoxicity of safrole and Ponceau MX (Crampton et al., 
1977) on rat livers. Liver enlargementaccompanied by an induction of 
microsomal drug-metabolising enzymes without cellular damage, was observed 
in the initial feeding stages for both compounds. However, when feeding 
was prolonged, rats treated with safrole exhibited both an inhibition of 
hepatic microsomal enzymes and the appearance of cytopathological changes. 
Histochemical studies at this stage showed a centrilobular depression of 
glucose 6-phosphatase, a departure from the normal pericanalicular 
distribution of lysosomal acid phosphatase and the presence of autophagic 
vacuoles. With Ponceau MX, however, drug-metabolising enzyme activities
were not below control values although a decrease in the cytochrome P-450 
content was found after 16 weeks of treatment (Crampton et al.,1977) and 
similar histochemical evidence of liver damage was observed as in safrole- 
treated animals.
In view of the above findings, comparable biochemical changes 
might be expected to precede the appearance of hepatic tumours in DDT-treated 
rats. In the present study, no evidence of liver damage in the chronically 
DDT-treated rats was found. The liver enlargement and-microsomal enzyme 
induction were sustained up to the end of the 32 week study. This type 
of response has been considered to reflect adaptive changes without liver 
injury as observed in long-term studies with butylated hydroxytoluene 
and phenobarbitone (Crampton et al., 1977a). In addition, early histo- 
chemical changes observed with safrole or Ponceau MX, e.g. a departure 
of lysosomal acid phosphatase activity from the normal pericanalicular 
distribution, was not found with DDT-treated rat liver samples. However, 
biphenyl 2-hydroxylase activity was markedly enhanced, in the DDT-treated 
animals, although no progressive increase in the absolute activity of this 
enzyme was detected. This is in contrast with the progressive elevation 
of biphenyl 2-hydroxylase activity, which may be associated with the 
degranulation of the endoplasmic reticulum and linked with hepatotoxicity,
in safrole-treated animals (Parke and Gray, 1978)•
The results obtained in this project also differ from that observed 
with dieldrin where a phenomenom termed hypertrophic hypoactive smooth 
endoplasmic reticulum (HHER) was exhibited (Hutterer et al., 1968). This 
phenomenom has been described in Chpater 4. Stevens et al. (1977) 
attribute the gradual decline in the extent of enzyme induction to a 
qualitative change in the induced cytochrome P-450 since the binding of 
type I substrates, such as aldrin and ethylmorphine, was significantly
reduced (Hutterer et al., 19?0). This may either be due to the induction 
of a new species of cytochrome P-450 after chronic administration or the 
presence of high levels of dieldrin in the liver interfering with the 
binding of other type I substrates. Since HHER was not exhibited In rats 
after chronic administration of dieldrin at a lower dose, the first 
explanation is unlikely unless another form of cytochrome P-450 can be 
induced by higher dose levels. The possibility that HHER is due to an 
accumulation, of dieldrin in the liver of treated-rats may also be ruled 
out for the concentration of dieldrin present in liver microsomes of 
treated-animals did not increase with the duration of treatment (Stevens 
et al., 1977).
Methylehedioxyphenyl compounds, such as safrole, are known to 
form a tight metabolic intermediate ligand complex with cytochrome P-450 
thus inhibiting various drug-metabolising enzyme activities (Gray, 1975; 
Elcombe.et al.,1975)• It would be of Interest to investigate the 
possibility of such an interaction with dieldrin. If such a complex is 
formed, a plausible explanation would be provided for the phenomenom of 
HHER as casued by dieldrin.
The present study therefore indicates that DDT does not produce 
any hepatotoxic effects in rats that have been kept chronically on diets, 
containing high levels of the compound. This also lends support to 
findings by various workers showing that compounds such as DDT, dieldrin 
and phenobarbitone are nonGarcinogenic to rats, and are carcinogenic only 
in mice. Furthermore, results obtained from human studies, which are 
described below, suggest that mouse data is apparently nonapplicable to 
man. .
Glemmensen et al. (1974) demonstrated that during a JO year 
period, no significant increase in the risk of cancer was observed in 
over nine thousand epileptic patients that had been given heavy daily 
doses of phenobarbitone during their treatment. This survey was further 
extended for five years, and it was argued strongly that phenobarbitone 
is noncarcinogenic to humans (Clemmensen and Hjdlgrim-Jensen, 1978). 
Similarly, DDT and dieldrin have not been found to increase the occurence 
of cancer in?workers heavily exposed to these insecticides (Ortelee, 1958; 
Laws et al., 1973; Hayes et al, 1971; Jager, 1970; Morgan and Roan, 1974; 
Van Raatle, 1977) • Some of the workers were exposed to these compounds 
for as long as 25 years without liver injury, although it may be argued 
that the case numbers for each. of these studies were too small for 
statistical evaluation.
Human studies showed not only the absence of excess tumours but 
furthermore no toxic changes were detected that would likely lead to 
cancer development. These results should probably carry more weight in 
the evaluation of the carcinogenic potential of these compounds to man 
than the data obtained from mouse experiments. It is, however, necessary 
to consider other factors such as induction of the mixed-function oxidases, 
as previously mentioned, before any compound can perhaps ' be considered 
safe, for the human diet consists of a variety of contaminants which may 
interact to produce adverse effects.
A P P E N D I X
APPENDIX
Tables Showing Changes in Drug-Metabolizing Enzymes and Related Parameters 
During Chronic Administration of DDT to Male Wistar Albino Rats
Units employed for various parameters were as follows;
p-Nitroanisole O-demethylase - nmol p-nitraphenol formed/mg microsomal
Results are means + S.E.M. obtained from six animals in all parameters 
except cholesterol 7tx-hydroxylase and 7-ethoxyresorufin O-deethylase
+ S.E.M. for four animals and four animal samples were pooled for the 
determination of insecticide levels in both liver and microsomes. 
Significant differences between values for control and treated groups are 
shown as follows:
a = P <C. 0.05* b = P <  0.01 and c = P 0.001.
Cytochrome b^
NADPH-cytochrome c reductase
Microsomal protein 
Cytochrome P-450
Aniline hydroxylase
mg/g liver 
nmol/g liver 
nmol/g liver
nmol cytochrome c reduced/mg microsomal 
protein/minute
nmol p-aminophenol formed/mgmicrosomal 
protein/minute
protein/mi:
Cholesterol 7^-hydroxylase nmol 7-hydroxylated cholesterol formed/ 
mg microsomal
Biphenyl 4- and 2-hydroxylases nmol 2- or 4- hydroxybiphenyl formed/ 
mg microsomal A
7-Efchoxyresorufin O-deethylase nmol resorufin formed/mg microsomal 
protein/minute
Insecticide residues Mg/g liver
where only four animals were used. At week 32* all results are means
Liver , ,.=— - wt. ratio Body?
x 10 ■
Microsomal
Protein
Cytochrome
.P-450
Cytochrome
b5 :
Day 10
-
Control 4.8 +0.1 3 2 + 1 0.8+0.04 0 .3 + 0.01
250 ppm 6.1 +0.1° 44 + 2° 2.1 +0.0?° 0.4 + 0.02
500 ppm 6.2 + o.lC 44 + 2° 2.1+0.04c 0.4 + 0.03
. WEEK 4
Control 4.0 + 0.2 ; 40 + 2 1.0 + 0.02 0.4+0.02
250 ppm 4.8 + 0.2^ 52 + 2° 2.2 + 0.05° 0.6+0.02°
500 ppm 4.9 + 0.213 48 + 2b 2.0 + 0,08 0.6 + 0.02°
WEEK 8
Control 3.6 + 0.1 3 9 + 2 0.9 + Q.04 0.4 + 0.02
250 ppm 4,6 + 0.1° 51 + 2C 2.0 + 0 .06° 0.6 + 0.02°
500 ppm 5.0 + 0.1° 5 8 + 2 ° 1.9 + 0.03° 0.6 +0.02°
WEEK 16
Control 3.0 + 0.04 34 + 2 1.2 + 0.1 0 .3 + 0.03
250 ppm 3.8 + 0.1° 49 + 1° 2.3 + 0.1° 0.4 + 0.02°
500 ppm 4.4 + 0.1° 4? + 2° 2.4 + 0.2° 0 .5 + 0.05°
WEEK 32
Control 3 .0 + 0.1 26 + 1 1.2 + 0.02 0 .6 + O .06
250 ppm 4,0 + 0.1° 34 + 1° 2 ,5 + 0.15° 1.0 + 0.12°
500 ppm 4,0 + 0.1° 34 +.1° 2.6 ± 0.25 ■ 1.0+0.09°
NADPH-Cytochrome Aniline 
c Reductase Hydroxylase
. p-N itro ani sole 
O-Demethylase
Cholesterol
7tx-Hydroxylase
DAY 10
Control 56 + 3 81 + 4 . 63 + 5 0.9 + 0.1
250 ppm 89 + 6° 123 + 5° 103 + 3° 1.3 + 0.1a
500 ppm 105 ± 5° 115 + 6° 120 + 11C 1.3 + o.ia
WEEK 4 - T
Control 4 3 + 2 71 ± 3 5 7 + 5 2.4 + 0.3
250 ppm 57 + 3 92 + Aa 124 + 10c 2.0 + 0.3
500 ppm 75 ±  3° 100 + 413 141 + 9C 2.0 +0.1
WEEK 8
Control 37 ±  2 78 + 3 3 9 + 3 1.5 + 0.3
250 ppm 66 +4° I06 + 6^* 72 + 3° 1.6 + 0.3
500 ppm 7 0 + 3 ° 94 + 413 71 + 3° 1 .5 + 0.1
WEEK 16
Control 51 + 3 114 + 6 N.D.
250 ppm 88 + 7° 158 + 5° 117 + 5° N.D.
500 ppm 93 + 8° 171 + 6b 123 + 8C N.D.
WEEK 32
Control 34 + 4 7 3 + 7 N.D, 1.6 + 0.3
250 ppm 48 + 4° 120 + 12^ N.D. 1.2 + 0.2
500 ppm 6l + 4C 128+5° N.D. 1.4 + 0.3
Biphenyl 4- 
Hydroxylase
Biphenyl 2- 
Hydroxylase
7-Ethoxyresorufin
0-Deethylase
DAY 10
Control 110 + 4 2 + 0.2 O.I9 +O.OI
250 ppm 317 + 8C 7 + 0.5° 0.54 + 0.04°
500 ppm 319 + 8° 9 + 0.3° 0.57 + 0.03°
WEEK 4
Control 8 9 + 3 1 + 0.1 0.12 + 0.01
250 ppm 193+7° 6+0.3° 0.39 + 0.05°
500 ppm 186 + 7C 7 + 0.4° 0.46 + 0.05°
WEEK 8
Control 80 + 3 0.4 + 0.1 0.07 + 0.02
250 ppm 180 + 10° 4 + 0.3° 0.22 + 0.03°
500 ppm 192+7° 4 + 0.2° 0.22 + 0.03°
WEEK 16
Control 121 + 6 0 .3 + 0.1 N.D.
250 ppm 272 + 17° 4 + 0.6° ' N.D.
500 ppm 260 + 18° 5 + 0.6° N.D.
WEEK 32
Control 1 0 7 + 2 0.2 + 0.06 0.07 + 0.01
250 ppm 352 + 32° 3.2 + 0.2° 0.28 + 0.01°
500 ppm 268 + 23° 3.5+ 0 .6° 0.32 + 0.05°
Insecticide Levels in Hepatic Microsomes of Rats Chronically Administered with
DDT
Treatment
Time DDT DDD DDE
250 ppm 20 + 2 14 + 1 1.4 + 0.1
DAY 10
500 ppm 27 + 4 • 24 + 1 2.0 + 0.1
250 ppm l6 + l 25 + 2 2 + 0.2
WEEK 4
500 ppm 27 + 3 41 + 1 5 + 0 .5
250 ppm 11 + 1 19 + 2 2 + 0.1
WEEK 8
500 ppm 24 + 4 31 + 6 4 + 0.6
WEEK 16
250 ppm 1 6 + 2 7 + 1 4 + 0.3
500 ppm 25 + 1 1 9 + 2 8 + 0.7
250 ppm 13 14 4
WEEK 32
50^ ppm 27 20 12
Insecticide Levels in Whole Liver of Rats Chronically Administered with DDT
Treatment
Time DDT DDD DDE v /:
250 ppm 4 + 0.3 4 + 0.2 0.4 + 0.01
DAY 10
500 ppm 6 + 1.2 7 + 0.9 1.0+0.14
WEEK 4
*250 ppm 4 + 0.2 3 + 0.3 0 .5 + 0.1
500 ppm 5 + 0.4 7 + 0 . 3 1.9 + 0.2
250 ppm 4 + 0.4 5 + 0 . 4 0.5 + 0.04
WEEK 8
500 ppm 4 + 0.4 14 + 1.0 2.0 +0.3
WEEK 16
250 ppm 4 + 0.6 2 + 0.2 0.8 + 0.1
500 ppm 5 + 0.5 3 + 0.3 1.7 + 0.04
250 ppm 7 5 2
WEEK 32
500 ppm 11 9 4
TOTAL INSECTICIDE (DDT +.DDD + DDE) LEVELS IN WHOLE LIVER
250 ppm 500 ppm
DAY 10 36 + 3 5 6 + 7
WEEK 4 : 42 + 2 V 73 + 3
WEEK 8 32 + 3 6 5 + 7
WEEK 16 '*■ 27 + 2 5 2 + 2
WEEK 32 31 59
TOTAL INSECTICIDE (DDT + DDD + DDE) LEVELS IN HEPATIC MICROSOMES
500 ppm
DAY 10
WEEK 4
WEEK 8
WEEK 16
WEEK 32
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